Sitemap
Oncology: Non-Hematologic
- Patient Questionnaire with Cancer Warning Signs
- When to Consider the Diagnosis of a Familial or Hereditary Cancer
- Clinical Criteria of Sanderson and Ironside for Referral of a Patient for Exclusion of a Cancer of the Head or Neck
- Risk Factors of Burgi et al for Non-AIDS Defining Cancers in an HIV-Positive Patient
- Risk of De Novo Malignancy in a Solid Organ Transplant Recipient
- Flow Cytometry for Estimation of S-phase Fraction
- Flow Cytometry to Calculate the DNA Index
- Histochemical Score for Immunohistochemical Tumor Markers
- Indications for Performing Electron Microscopy on a Tumor
- Criteria of Som for Lymph Node Metastasis on a CT Image
- Histologic Parameters and Prognosis in Squamous Cell Carcinoma of the Oropharynx
- Prediction of Metastases to Cervical Lymph Nodes from Squamous Cell Carcinoma of the Tongue and Floor of the Mouth Based on the Histologic Malignancy Score and Vascular Invasion
- Risk Factors for Malignant Neoplasm in the Adult Tonsil
- Histopathologic Malignancy Score of Jakobsson et al in Squamous Cell Carcinoma of the Head and Neck
- TNM Staging for Cancers of the Lip and Oral Cavity
- T and N Integer Score (TANIS) Staging System for Squamous Cell Carcinoma of the Oral Cavity
- Functional Severity Index and Extended Clinical Severity Staging System for Cancer of the Tongue or Floor of the Mouth
- Risk Factors for Squamous Cell Carcinoma of the Lip
- Risk Factors for Lymph Node Metastasis in Patients with Squamous Cell Carcinoma of the Lip
- M.D. Anderson Risk Scores for Head and Neck Cancer Recurrence at the Primary Site and in the Neck
- M.D. Anderson Risk Factors for Recurrence in Patients with Cancer of the Head and Neck
- Predictors of Medow et al for Patients with Squamous Cell Carcinoma of the Head and Neck
- TNM Staging for Cancers of the Hypopharynx
- TNM Staging for Cancers of the Oropharynx
- Pretreatment Probability Model of van den Broek et al for 2 Year Survival After Intra-arterial Chemoradiation in a Patient with Advanced Head and Neck Carcinoma
- Pretreatment Probability Model of van den Broek et al for 2 Year Local Control After Intra-arterial Chemoradiation in a Patient with Advanced Head and Neck Carcinoma
- Prognostic Factors of Argiris et al for a Patient with Recurrent or Metastatic Carcinoma of the Head and Neck
- Histologic Features of Saywell and Weedon in Squamous Cell Carcinoma of the Lip Associated with Metastatic Disease
- DIAGS Index of Mori et al for Predicting Lymph Node Metastases in a Patient with a Squamous Cell Carcinoma of the Oral Cavity
- The Clinical Severity Staging System of Pugliano et al for Carcinoma of the Oral Cavity
- Immunohistochemical Patterns of Zarovnaya and Black Distinguishing Pseudoepitheliomatous Hyperplasia (PEH) from Squamous Cell Carcinoma (SCC)
- Prognostic Indicators of Le Tourneau et al for Survival in a Patient with a Squamous Cell Carcinoma of the Head and Neck
- Grades of Ojiri et al for CT Scan Documented Response to Therapy of an Oropharyngeal Squamous Cell Carcinoma
- Risk Factors of Garavello et al for Distant Metastases in a Patient with Squamous Cell Carcinoma of the Head and Neck
- Risk Factors of Liao et al for Distant Metastases in a Patient with Squamous Cell Carcinoma of the Oral Cavity
- Nomogram of Tanvetyanon et al for Predicting Survival in a Patient Undergoing Reirradiation for a Head and Neck Cancer Arising in a Previously Irradiated Site
- Basaloid Squamous Cell Carcinoma of the Head and Neck
- Model of van den Broek et al for Predicting Local Control of an Advanced Head and Neck Squamous Cell Carcinoma Treated with Intra-Arterial Chemoradiation
- Model of van den Broek et al for Predicting 2 Year Overall Survival for a Patient with an Advanced Head and Neck Squamous Cell Carcinoma Treated with Intra-Arterial Chemoradiation
- Classification Scheme of Ho for Nasopharyngeal Carcinoma
- Prognostic Factors of Heng et al for Nondisseminated Nasopharyngeal Carcinoma
- Model of Waldron and Witterick for Predicting Survival in a Patient with Paranasal Sinus Cancer Based on the Clinical Extent of the Primary Tumor
- Istituto Nazionale per lo Studio e la Cura dei Tumori (INT) Classification of Malignant Ethmoid Tumors
- TNM Staging for Cancer of the Maxillary Sinus
- TNM Staging for Cancer of the Nasopharynx
- TNM Staging for Cancer of the Nasal Cavity and Ethmoid Sinus
- Prognostic Model of Leung et al for a Patient with Nasopharyngeal Carcinoma Based on Plasma EBV DNA Load and TNM Stage
- Score of Grandi et al for Staging a Patient with Nasopharyngeal Cancer
- Modified Kadish Staging System for Esthesioneuroblastoma (Olfactory Neuroblastoma)
- Prognostic Scores of Neel et al for a Patient with Nasopharyngeal Carcinoma (NPC)
- Histologic Grading Criteria of Hyams for Esthesioneuroblastoma (Olfactory Neuroblastoma)
- Prognostic Index Score of Ong et al for Metastatic Nasopharyngeal Carcinoma
- TNM Classification and Staging of Salivary Gland Tumors
- Prognostic Scores of Vander Poorten et al for Patients with Parotid Carcinoma
- Revised TNM Classification and Staging of Salivary Gland Tumors
- Grading Criteria of Goode et al for Mucoepidemoid Carcinoma of Salivary Glands (AFIP Criteria)
- Grading Criteria of Brandwein et al for Mucoepidermoid Carcinoma of Salivary Glands (Modified AFIP Criteria)
- Grading Criteria of Healey et al for Mucoepidermoid Carcinoma of Salivary Gland Origin
- Risk Factors of de Brito Santos for Cervical Lymph Node Metastases in a Patient with a Parotid Carcinoma
- Risk Factors of Sung et al Associated with Metastastic Adenoid Cystic Carcinoma Arising in the Head or Neck
- Model of Carrillo et al for Predicting Recurrence of a Parotid Carcinoma
- Histologic Grades of Szanto et al for Adenoid Cystic Carcinoma of a Salivary Gland
- Histologic Features of Adenoid Cystic Carcinoma with High Grade Transformation (Dedifferentiation)
- Histologic Features of Gomez et al Impacting Prognosis for a Patient with an Acinic Cell Carcinoma of the Parotid Gland
- Use of Stage and p63 Immunostaining to Predict Prognosis for a Patient with an Adenoid Cystic Carcinoma Arising in a Salivary Gland
- Risk Factors of Bhayani et al for Distant Metastases in a Patient with Clinical Stage I or II Adenoid Cystic Carcinoma Arising in a Major Salivary Gland
- Prognostic Factors in Osteogenic Sarcoma of the Jaws
- Classification of Odontogenic Carcinomas
- Histologic Features of an Ameloblastic Carcinoma
- The Symptomatic-Anatomic-Comorbid (SAC) Staging System of Feinstein et al for Cancer of the Larynx
- Composite Laryngeal Recurrence Staging System (CLRSS) of Lacy and Piccirillo for Recurrent Laryngeal Squamous Cell Carcinoma
- TNM Staging of Bhattacharyya for Tracheal Carcinoma
- Criteria of Lewis et al for Basaloid Squamous Cell Carcinoma (BSCC) of the Larynx
- Prognosis in Medullary Carcinoma of the Thyroid
- Staging for Papillary and Follicular Thyroid Carcinoma
- MACIS Prognostic Score for Papillary Thyroid Carcinoma
- AMES Prognostic Groups in Patients with Thyroid Carcinoma
- The EORTC Thyroid Cancer Cooperative Group Prognostic Index for Thyroid Carcinoma
- The AGES Prognostic Score for Papillary Thyroid Carcinoma
- Prediction of Malignancy for Nonfollicular Thyroid Neoplasms Based on the Ultrasound Features of Koike et al
- Risk Factors from the NCCN Guidelines for Stratifying Patients with a Well-Differentiated Thyroid Cancer
- Prognostic Factors of Shoup et al for a Patient with Metastatic Differentiated Thyroid Carcinoma
- The VAN and SAG Scores of Akslen for Evaluating a Patient with a Papillary Thyroid Carcinoma
- Indicators of Ohshima et al for Performing a Bilateral Modified Radical Neck Dissection in a Patient with a Papillary Thyroid Carcinoma
- Clinical Findings Suspicious for Thyroid Carcinoma in a Euthyroid Patient with a Solitary Thyroid Nodule
- Prognostic Factors of Cushing et al for a Patient with Well-Differentiated Thyroid Carcinoma
- Pretreatment and Posttreatment Scores of Yildirim for Predicting Risk in a Patient with a Differentiated Thyroid Carcinoma
- Staging System of Shin et al for a Papillary Thyroid Carcinoma with Local Airway Invasion
- Risk Factors of Ghossein et al for Recurrence of an Encapsulated Hurthle Cell Carcinoma of the Thyroid Gland
- Quantitative Alternative to the TNM Stage (QTNM) for Differentiated Thyroid Cancer
- Strategy of Pacini et al for Monitoring a Patient with a History of Differentiated Thyroid Carcinoma
- Prognostic Factors of Sugitani and Fujimoto for a Patient with a Papillary Microcarcinoma of the Thyroid Gland
- Prognostic Index of Sugitani et al for a Patient with Anaplastic Thyroid Carcinoma
- Prognostic Factors of Lopez-Penebad et al for a Patient with a Hurthle Cell Neoplasm of the Thyroid
- 1992 TNM Classification and Staging of Lung Carcinoma
- Prognostic Staging System of Sagman et al for Small Cell (Oat Cell) Carcinoma of the Lung
- Prognostic Factor Risk Index of Shinkai et al for Advanced Non-Small-Cell Lung Cancer
- Prognostic Index of Wigren et al for a Patient with a Non-Small Cell Lung Cancer
- Criteria for Pulmonary Neuroendocrine Tumors
- Clinical Severity Staging System for Lung Cancer of Feinstein and Wells
- Prognostic Factors of Beasley et al for Pulmonary Atypical Carcinoid Tumors
- Modified Scar Grade of Maeshima et al for Small Peripheral Lung Adenocarcinomas
- Clinical Features of the Pancoast Syndrome in a Patient with Lung Cancer
- Criteria of Gal et al from the AFIP for Pulmonary Fibrohistiocytic Tumors
- Prognostic Factors of Albain et al from the Southwest Oncology Group (SWOG) for Extensive-Stage Non-Small-Cell Lung Cancer
- Prognostic Factors of Paesmans et al for a Patient with Advanced Non-Small-Cell Lung Cancer
- Prognostic Factors of Suzuki et al for a Patient with a Surgically Resected Non-Small Cell Lung Carcinoma
- Grading Criteria of Suzuki et al for Non-Small Cell Carcinomas of the Lung
- Model of Hoang et al for Predicting Survival in a Chemonaive Patient with Advanced Non Small Cell Lung Cancer Treated with Platinum-Based Doublet Chemotherapy
- Pretreatment Prognostic Score of Maestu et al for a Patient with Small Cell Lung Cancer
- Prognostic Factors of Takigawa et al for a Patient with Advanced Non-Small Cell Lung Cancer (NSCLC)
- Prognostic Index of Vincent et al for Small Cell Lung Cancer
- Prognostic Model of Cerny et al for a Patient with a Small Cell Lung Cancer (Manchester Score)
- Prognostic Model of Souhami et al for a Patient with Small Cell Carcinoma of the Lung
- Prognostic Model of Mandrekar et al for Advanced Non-Small Cell Lung Cancer (NSCLC)
- Monitoring Serum Neuron-Specific Enolase (NSE) in a Patient with a Small Cell Carcinoma of the Lung
- Prognostic Scores of Forrest et al for a Patient with Inoperable Non-Small-Cell Carcinoma of the Lung (Glasgow Prognostic Score)
- Prognostic Indices of Muers et al for a Patient with Non-Small Cell Lung Cancer
- Criteria of Martini and Melamed for the Diagnosis of Synchronous Primary Lung Carcinomas
- Prognostic Factors of Ou et al for Survival in a Patient with Non-Small Cell Lung Cancer
- Model of Park et al for Predicting Outcome for a Patient with a Nonsmall Cell Lung Cancer Treated with Gefitinib As Salvage Therapy
- Risk Factors for Lung Cancer
- Endobronchial Carcinoid Tumor Mimicking Asthma
- Histologic Features of Kelsey et al Predictive of Local Recurrence in a Patient Following Surgery for Early Stage Nonsmall Cell Lung Cancer
- Immunohistochemical Score of Ring et al for Classification of Non-Small Cell Lung Carcinoma
- Hazard Score of Yamaguchi et al for Determining the Prognosis for a Patient with an Adenocarcinoma of the Lung
- Prognostic Molecular Markers of Lu et al for a Patient with Stage I Non-Small Cell Lung Cancer (NSCLC)
- Presenting Signs and Symptoms for a Patient with Lung Cancer
- Clinical and Laboratory Findings of Metastatic Disease in a Patient with Lung Cancer
- Paraneoplastic Syndromes Seen in Patients with Lung Cancer
- Predictive Factors of Ando et al for Antitumor Response and Survival in a Patient with Non-Small Cell Lung Cancer Treated with Gefitinib
- Prognostic Factors of Paesmans et al for a Patient with a Small Cell Lung Carcinoma (SCLC)
- Algorithm of Rekhtman et al for Using Immunostains to Classify a Non-Small Cell Lung Carcinoma (NSCLC)
- Algorithm of Cheng et al for Molecular Testing of a Lung Adenocarcinoma, Starting with EGFR Mutation Testing
- Algorithm of Cheng et al for Molecular Testing of a Lung Adenocarcinoma, Starting with KRAS Mutation Testing
- Prognostic Factors of de Cos Escuin et al for a Patient with Stage III Non-Small Cell Lung Cancer Undergoing Combined Chemotherapy and Radiation
- False-Positive and False-Negative Findings for Lung Cancer Associated with Positron Emission Tomography (PET)
- Distinguishing Pulmonary Enteric Adenocarcinoma from Metastatic Colorectal Adenocarcinoma
- Primary Adenoid Cystic Carcinoma (ACC) of the Lung
- Staging System of the Veterans Administration Lung Cancer Study Group (VALCSG) for Small Cell Lung Carcinoma (Limited versus Extensive Stage Disease)
- Stent Placement to Relieve Major Airway Obstruction Caused by a Lung Tumor
- Indications to Perform a Pleurodesis in a Patient with Lung Cancer and a Malignant Pleural Effusion
- Monitoring Response to Pleurodesis for Malignant Pleural Effusion in a Patient with Lung Cancer
- Significance of a Pleural Fluid Accumulation in a Patient with a Localized Lung Cancer
- Circulating Tumor Cells (CTC) in a Patient with Lung Cancer
- Predictors of Prevost et al for Mortality in a Patient with a Non-Small Cell Lung Cancer (NSCLC)
- Detection of an EGFR Mutation in a Non-Small Cell Lung Carcinoma Using Immunohistochemistry (IHC)
- Detection of the EML4-ALK Translocation in Lung Adenocarcinoma Using the Vysis ALK Break Apart FISH Probe
- Visceral Pleural Invasion (VPL) in Lung Cancer
- N Stage for a Lung Cancer and the International Association for the Staging of Lung Cancer (IASLC) Lymph Node Map
- Adrenalectomy for an Isolated Metastasis from a Non-Small Cell Lung Carcinoma
- Histologic Subtypes of Sarcomoid Carcinoma of the Lung
- Score of Barletta et al for Grading a Lung Adenocarcinoma
- Criteria of Machtay et al for Local-Regional Failure Following Radiation Therapy in a Patient with Lung Cancer
- Risk Factors of Higginson et al for Palliative Thoracic Radiation Therapy Following First-Line Chemotherapy in a Patient with Advanced Non-Small Cell Lung Carcinoma
- Recommendations for Annual Lung Cancer Screening from the Lung Cancer Guidelines Third Edition (LCIII) of the American College of Chest Physicians (ACCP)
- Clinical Staging System for Thymoma of Masaoka et al
- Prognostic Analysis of Thymoma of Pescarmona et al
- TNM Classification for Thymoma
- Prognostic Factors of Zisis et al for Survival in a Patient with a Completely Resected Thymic Epithelial Tumor
- World Health Organization (WHO) Histologic Classification for a Thymic Epithelial Tumor
- Prognostic Factors of Burke et al for Primary Sarcomas of the Heart
- Elston's Modification for the Criteria of Bloom and Richardson in the Histologic Grading of Infiltrating Ductal Carcinoma
- Prognostic Index of Haybittle et al for Infiltrating Ductal Carcinoma (Nottingham Prognostic Index, NPI)
- Van Nuys Prognostic Index for Ductal Carcinoma In Situ
- TNM Classification and Clinical Staging of Breast Carcinoma
- Prognostic Factors in Breast Carcinoma
- Scoring Breast Cosmesis Following Therapy
- Absolute and Relative Contraindications to Breast Conservation Treatment with Radiation
- Relative Risk for Subsequent Invasive Breast Cancer Associated with Changes Seen in Breast Biopsies
- Evaluating a Woman's Risk of Developing Breast Cancer Based on Her Family's Cancer History
- Grading Ductal Carcinoma in Situ Using the AFIP System of Tavassoli et al
- Prognostic Score of Chevallier et al for Histological Node Negative Breast Carcinoma
- Prediction of Metastases to Axillary Lymph Nodes in Women with Invasive Breast Carcinoma
- The Model of Gail et al for Predicting the Probability of Developing Breast Cancer in White Women Examined Annually: Calculating the Relative Risk
- The Model of Gail et al for Predicting the Probability of Developing Breast Cancer in White Women Examined Annually: Calculating the Absolute Risk
- The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: First Degree Relatives with Breast Cancer
- The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: Mother and Aunt with Breast Cancer
- The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: Second Degree Relatives with Breast Cancer
- The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: Relatives with Ovarian Cancer
- The Prognostic Index of Yamamoto et al for Women with Metastatic Breast Carcinoma
- Factors of Lambert et al for Predicting Nipple Involvement in Women with Breast Cancer
- Standardized Instrument of Petrek et al for Detecting Lymphedema in a Patient with Breast Cancer Following Axillary Lymph Node Dissection
- The Triple Test Score (TTS) for Palpable Breast Masses
- Criteria of Rosen for Identification of Lymphatic Tumor Emboli in Breast Carcinoma
- Histologic Grading of Phyllodes Tumor
- 2 mm Size Rule of Tavassoli for Ductal Carcinoma in Situ (DCIS)
- Factors Associated with Response to Neoadjuvant Chemotherapy in Women with Breast Carcinoma
- Infiltrating Ductal Carcinoma with Extensive Ductal Carcinoma in Situ (DCIS)
- The Modified Triple Test Score (MTTS) for a Palpable Breast Mass
- Probability of Successful Mapping of the Axillary Sentinel Lymph Nodes for Breast Cancer Based on the Woman's Age and Body Mass Index (BMI)
- Risk Factors for Breast Cancer in a Male
- Decision Tree of Banerjee et al for Prognosis in Women with Breast Cancer
- Clinical Factors of Clarke et al Affecting the Cosmetic Result in a Woman with Stage I or II Breast Cancer Treated by Biopsy and Irradiation
- Indications for Performing a Mastectomy in a Woman with a Phyllodes Tumor
- Nucleus Fibrotic Focus Fat Invasion (NNF) Classification of Hasebe et al for Invasive Ductal Carcinoma of the Breast
- Model of Kattan et al for Predicting Mortality in a Woman with Breast Cancer Who Does Not Receive Adjuvant Therapy
- Histologic Features of Stalsberg and Harmann for Infiltrating Tubular Carcinoma of the Breast Associated with Good Prognosis
- Risk Categories from the 1998 St. Gallen Conference for Node Negative Breast Cancer in a Woman
- Prognostic Factors of Kuru et al for Node Negative Breast Carcinoma in a Woman
- Risk Categories from the 2001 St. Gallen Conference for Node Negative Breast Cancer in a Woman
- Treatment Recommendations for a Woman with Operable Breast Cancer From the 2001 St. Gallen Conference
- Model of Viale et al for Predicting Risk of Metastasis to Axillary Sentinel Lymph Nodes in a Patient with Breast Cancer
- M.D. Anderson Prognostic Index (MDAPI) for Selecting a Woman with Breast Cancer for Breast Conserving Therapy After Neoadjuvant Chemotherapy
- Risk Factors of Stolier and Grube for Nipple or Areola Involvement in a Woman with Primary Breast Carcinoma
- Risk Factors of Gonzalez-Angulo et al Predictive for Distant Metastases in a Woman with Breast Cancer and a Complete Response to Neoadjuvant Chemotherapy
- Nomogram of Hennessy et al for Predicting Residual Tumor in Axillary Lymph Nodes Following Primary Chemotherapy for Breast Carcinoma
- Nomogram of Rouzier et al for Predicting Complete Pathologic Response of a Breast Cancer to Preoperative Anthracycline Chemotherapy
- Nomogram of Rouzier et al for Predicting the 5 and 10 Year Probabilities of Freedom from Distant Metastasis in a Woman with Residual Breast Cancer After Preoperative Anthracycline Chemotherapy
- Histologic Grading of Lobular Carcinoma of the Breast Using the Bloom Richardson Score
- Histologic Grades of Donnell et al for Angiosarcoma of the Breast
- Factors of Chen et al for Identifying Increased Risk of Supraclavicular Lymph Node Metastases in Breast Carcinoma
- Criteria of Isaacs et al for Counseling and Testing a Patient for BRCA1 and BRCA2 Mutations
- Risk Factors of Dillon et al for Predicting Invasive Breast Cancer in a Woman with DCIS on Core Biopsy
- Pedigree Assessment Tool (PAT) of Hoskins et al for Identifying a Woman at High Risk for Hereditary Breast Cancer
- Predictors of Huo et al for Invasive Carcinoma in a Patient with Ductal Carcinoma in Situ (DCIS) Diagnosed on a Needle Core Biopsy
- Tamoxifen Indication Score (TIS) of Rahman et al for a Woman with Breast Cancer
- Criteria of Silver and Tavassoli for Minimally Invasive (Microinvasive) Breast Carcinoma
- Histologic Features of Pleomorphic Invasive Lobular Carcinoma
- Nomogram of Bevilacqua et al for Predicting Metastases to a Sentinel Lymph Node
- J-Score for Reporting Estrogen Receptor Status by Immunohistochemistry for a Woman with Breast Cancer
- Nomogram of Hanrahan et al for Survival in a Woman with a T1a,bN0M0 Breast Carcinoma
- Allred Score for Reporting Estrogen Receptor Status by Immunohistochemistry for a Woman with Breast Cancer
- Score of Acs et al for E-Cadherin Immunostaining in a Breast Carcinoma
- Nomogram of Katz et al for Identifying a Woman with Breast Cancer and a Positive Sentinel Lymph Node Biopsy Who Probably Has Metastases in 4 or More Lymph Nodes
- Clinical-Pathologic Scoring System (CPS and CPS+EG) of Jeruss et al for Evaluating a Woman with Breast Cancer After Neoadjuvant Therapy
- N+P (Nuclear Grade and Proliferation Index) Scheme of Tawfik et al for Grading Invasive Ductal Carcinoma
- Tenon Axillary Scoring System of Barranger et al for Predicting Metastasis Status of Non-Sentinel Axillary Lymph Nodes in a Woman with Breast Cancer
- Reasons for a Delay in the Diagnosis of Breast Cancer
- Distinguishing Lobular from Ductal Carcinoma By Use of Immunostains to E-Cadherin and High Molecular Weight Cytokeratin
- The N+P Histologic Grading System of Stevens et al for Invasive Lobular Carcinoma
- Risk Factors of Rowell for Locoregional Recurrence (LRR) in a Woman with Node-Negative Breast Cancer
- Risk Factors of Cheng et al for Locoregional Recurrence (LRR) in Women with T1 or T2 N1M0 Breast Cancer
- Model of Kohrt et al for Predicting Non-Sentinel Lymph Node Status in a Woman with Breast Cancer and a Positive Sentinal Lymph Node (Stanford Online Calculator)
- Model of Ratanawichitrasin et al for Predicting the Likelihood of Residual Ductal Carcinoma in Situ (DCIS) Following Therapy
- Risk Model of Wallgren et al for Locoregional Recurrence in a Woman Treated for Breast Cancer
- Indications of O'Shaughnessy for Performing Ductal Lavage on a Woman
- Criteria of Ridolfi et al for Medullary Carcinoma of the Breast
- Management Protocol of O'Shaughnessy et al for a Woman at High Risk for Breast Cancer Based on Ductal Lavage Cytology Results
- Prognostic Factors of Carter et al for a Woman with Invasive Breast Cancer
- Criteria of Hughes at al for Providing Additional Therapy to a Woman with Ductal Carcinoma in Situ (DCIS)
- Grading System of Hasebe et al for Lymphatic Tumor Emboli in a Woman with Invasive Ductal Carcinoma
- Model of Graesslin et al for Predicting the Risk of Brain Metastases in a Woman with Metastatic Breast Cancer
- Nomogram of Rudloff et al for Predicting Local Recurrence Risk Following Breast Conserving Therapy for Ductal Carcinoma in Situ (DCIS)
- Criteria of Tavassoli for Atypical Papilloma and Carcinoma Arising in a Papilloma
- Pathologic Features of an Angiosarcoma of the Breast
- Clinical Presentation of Paget's Disease of the Nipple
- Prognostic Factors of Panet-Raymond et al for a Woman with Recurrent Cancer in the Ipsilateral Breast
- Risk Factors of Pimiento et al for Local Recurrence of a Phyllodes Tumor
- Risk Factors of Brinton for Breast Cancer in a Male with Klinefelter's Syndrome
- Classification of Ragazzi et al for Mitochondrial Content of Oncocytic and Other Invasive Breast Carcinomas
- Gene Expression Patterns of Sorlie et al for Breast Carcinoma
- Nomogram of Timmers et al for Identifying a Woman with Breast Cancer Based on Findings Identified on Screening Mammography
- Histologic Parameters for Grading Squamous Cell Carcinoma of the Esophagus
- Clinical Risk Factors for Adenocarcinoma Arising in Barrett's Esophagus
- Revised TNM Classification of Eloubeidi et al for Esophageal Carcinoma Based on Tumor Length
- Grading Histologic Tumor Regression Following Preoperative Chemoradiotherapy for Esophageal Carcinoma
- Prognostic Index of Chau et al for Patients with Locally Advanced or Metastatic Esophago-Gastric Cancer
- Prognostic Factors of Rades et al for Overall Survival in a Patient with a Stage II or III Esophageal Carcinoma
- Indications for Endoscopic Mucosal Resection (EMR) of a Superficial Carcinoma of the Esophagus
- Classification of Siewert et al for Adenocarcinoma at the Gastroesophageal Junction
- Risk Factors of Sauvanet et al for Complications in a Patient Undergoing Surgical Management of an Adenocarcinoma at the Gastroesophageal Junction (GEJ)
- Classification of Radical Resections (R) for Adenocarcinoma at the Gastroesophageal Junction (GEJ)
- Risk Score of Steyerberg et al for 30 Day Mortality After Surgery for Esophageal Cancer
- Complications of Djarv et al Following Surgical Resection of an Esophageal Carcinoma
- Prognostic Factors of Yendamuri et al Determining Survival for a Patient with Esophageal Cancer
- Prognostic Score of Marubini et al in Gastric Carcinoma
- TNM Staging of Gastric Carcinomas
- Prognostic Factors of Shiu et al for Adenocarcinoma of the Stomach
- Prognostic Factors of Okada et al for Adenocarcinoma of the Stomach
- Classification of the Gross Appearance in Gastric Carcinomas (Early and Borrmann Types)
- Treatment Algorithm of Lowy et al for Gastric Cancer
- Risk Factors of Marrelli et al for Liver Metastases After Surgical Resection of a Gastric Adenocarcinoma
- Postoperative Nomogram of Kattan et al for Predicting Disease-Specific Survival in a Patient With Gastric Carcinoma and No Residual Disease (R0)
- Indications of Soetikno et al for Endoscopic Mucosal Resection (EMR) of a Superficial Gastric Carcinoma
- Postrecurrence Risk Score of Bennett et al for Predicting Survival in a Patient with Recurrent Gastric Carcinoma
- Criteria of Gotoda et al for Local Therapy of an Early Gastric Cancer
- Prognostic Factors of Adachi et al for a Patient with an Alpha Fetoprotein (AFP) Producing Gastric Carcinoma
- Criteria for the Diagnosis of Hereditary Diffuse Gastric Cancer
- Risk Factors of Persiani et al for Complications After Surgery for Gastric Cancer
- Prognostic Factors of Kooby et al for a Patient with Gastric Carcinoma and Negative Lymph Nodes
- Flow Diagram of Lee et al for Laparoscopic Wedge Resection of a Gastric Submucosal Tumor
- Prognostic Model of Lorenzen et al for Patients with Gastric Cancer
- TNM Staging of Colon Cancer
- Doubling Time of CEA Concentrations and Prognosis in Recurrent Gastric and Colorectal Carcinoma
- Prognostic Score of Diez et al for Colorectal Adenocarcinoma Based on Histopathologic Features
- Hereditary Nonpolyposis Colorectal Cancer (HNPCC): Lynch Classification
- Grading and Prognostic System for Rectal Carcinoma of Jass et al
- Lifetime Risk for Colorectal Carcinoma According to Houlston et al
- West Midlands Screening Criteria for a Person with a Family History of Colorectal Carcinoma
- Hereditary Nonpolyposis Colorectal Cancer (HNPCC): Original and Revised Bethesda Guidelines
- Management of the Patient with Adenocarcinoma in a Colonic Adenomatous Polyp
- Risk Factors of Nascimbeni et al for Predicting Lymph Node Metastasis in Patients with T1 Carcinoma of the Colon or Rectum
- Cumulative Prognostic Index of Petersen et al for a Patient with Duke's B Colon Carcinoma
- UK National Health Service (NHS) and Department of Health Risk Criteria for Colon Cancer
- Risk Factors of Merkel et al for Patients with Stage II Colon Carcinoma
- Criteria of Bouzourene et al for Assessment of Tumor Regression After Preoperative Radiotherapy of Locally Advanced Rectal Carcinoma
- Prognostic Index of Graf et al for Patients with Advanced Colorectal Carcinoma
- Risk Stratification Tree of Radespiel-Troger et al for Predicting Recurrence After Curative Resection of Colon Carcinoma
- Criteria of Cooper for the Diagnosis of a Squamous Cell Carcinoma of the Colon or Rectum
- Risk Factors of Fujimoto et al for Liver Metastases in a Patient with Colorectal Carcinoma
- ACPGBI (Association of Coloproctology of Great Britain and Ireland) Score for Predicting Mortality in a Patient Undergoing Resection of a Colorectal Cancer
- Predictors of Das et al for Downstaging a Rectal Cancer Treated with Preoperative Chemoradiation
- Hereditary Nonpolyposis Colorectal Cancer (HNPCC): Amsterdam Criteria
- Prognostic Factors of Gervaz et al for a Cirrhotic Patient with a Colorectal Adenocarcinoma
- Use of the Bethesda Panel to Determine Microsatellite Instability (MSI) in a Colorectal Carcinoma
- Molecular Classification of a Colorectal Carcinoma Based on Microsatellite Instability (MSI) and CpG Island Methylator Phenotype (CIMP)
- Histologic Features Suggestive of Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC)
- Indications for K-ras Testing and Cetuximab Therapy for a Patient with Colorectal Cancer
- Clinical Signs and Symptoms in a Patient with Colorectal Carcinoma
- Sites of Metastases in a Patient with Colorectal Cancer
- Criteria of Loy and Kaplan for Villous Adenocarcinoma of the Colon
- Steps to Prevent Colorectal Cancer
- Recommendations of Ribic et al for Identifying a Patient with Colon Cancer Who Is a Candidate for Fluorouracil-Based Adjuvant Chemotherapy Using Stage and Microsatellite Instability Status
- Factors Affecting the Number of Lymph Nodes Retrieved in a Colectomy Specimen Resected for Colon Carcinoma
- Log Odds of Positive Lymph Nodes (LODDS) in a Patient with Colon Cancer
- Classification of Pai et al for Mucinous Neoplasms of the Appendix
- Nomograms of Weiser et al for Predicting Survival in a Patient Following Curative Colectomy for Colon Cancer: Nomograms A and B
- Nomograms of Weiser et al for Predicting Survival in a Patient Following Curative Colectomy for Colon Cancer: Nomogram C
- Screening a Patient for Colorectal Adenoma or Cancer with Plasma SEPT9 (Septin 9) Methylated DNA
- Immunohistochemical Demonstration of DNA Mismatch Repair (MMR) Proteins to Identify a Patient with Lynch Syndrome (Hereditary Nonpolyposis Colon Cancer, HNPCC)
- Molecular Biomarkers in a Patient with Metastatic Colon Cancer Being Considered for Targeted Therapy with a Monoclonal Antibody to EGFR
- Predicting Survival in a Patient with Stage IV Colorectal Cancer Using the Glasgow Prognostic Score (GPS)
- Immunohistochemical Algorithm of Neumann et al for Determining the Risk of Distant Metastases in a Patient with a Cancer Arising in the Right Colon
- Criteria of Li et al for Testing for BRAF Mutations in a Colorectal Cancer
- Prognostic Factors in Extragastrointestinal Stromal Tumors
- Risk Factors of Fletcher et al for Aggressive Behavior in Gastrointestinal Stromal Tumors (GIST)
- Diagnosis of Spindle Cell Tumors of the Gastrointestinal Tract with Immunoperoxidase Staining
- Gastrointestinal Stromal Tumor (GIST) Risk Score of Nilsson et al
- Risk Factors of Van Glabbeke et al for Early or Late Resistance to Imatinib in a Patient with a Gastrointestinal Stromal Tumor (GIST)
- Phenotypic Changes in a Gastrointestinal Stromal Tumor (GIST) After Therapy with Imatinib Mesylate
- Criteria of Yokoi et al for Malignancy in a Gastrointestinal Stromal Tumor (GIST)
- Predictors of DeMatteo et al for Recurrence of a Localized Gastrointestinal Stromal Tumor (GIST) Following Resection
- Clinical Staging System of Woodall et al for Gastrointestinal Stromal Tumors (GIST)
- Risk Categories of Joensuu for a Gastrointestinal Stromal Tumor (GIST)
- Prognostic Nomogram of Gold et al for a Gastrointestinal Stromal Tumor (GIST)
- Okuda Staging System for Hepatocellular Carcinoma
- Prognostic Factors in Advanced Hepatocellular Carcinoma
- Prognostic Score of Iwatsuki et al to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation
- Algorithm of Terkivatan et al for the Management of a Solitary Solid Liver Tumor
- Hepatocellular Prognostic Index (HPI) of Lauwers et al for Patients with Completely Resected Hepatocellular Carcinomas
- The Chinese University Prognostic Index (CUPI) for Hepatocellular Carcinoma
- Molecular Classification of Hepatocellular Carcinoma Based on Estrogen Receptor Transcripts
- Prediction Score of Yamanaka et al for Selecting Surgical Treatment of Liver Cancer
- Prognostic System of the Cancer of the Liver Italian Program (CLIP)
- Simplified T Classification of Vauthey et al for Hepatocellular Carcinoma
- TNM Classification for Hepatocellular Carcinoma
- The Pretreatment Extent of Disease (PRETEXT) System for Describing Hepatocellular Carcinoma
- Criteria for Response to Therapy of the International Society of Pediatric Oncology Group for a Patient with Hepatocellular Carcinoma
- The Barcelona-Clinic Liver Cancer (BCLC) Staging Classification for Hepatocellular Carcinoma
- The French Classification of Chevret et al for Hepatocellular Carcinoma (GETCH Score)
- Clinical Prognostic Model of Tan et al for Hepatocellular Carcinoma
- Monitoring Strategy of Bruix et al for Hepatocellular Carcinoma in a Patient with Cirrhosis
- Classification of the Children's Cancer Study Group (CCSG) for Hepatoblastoma
- CAP (C-Reactive Protein, Albumin, Platelet Count) Score of Hashimoto et al for a Patient with Hepatocellular Carcinoma
- Prognostic Score of Pawlik et al for Predicting Survival After Resection of a Large Hepatocellular Carcinoma
- Criteria of Arrieta et al for the Diagnosis of Hepatocellular Carcinoma in a Patient with Cirrhosis Based on Serum Alpha Fetoprotein (AFP) Levels
- Prognostic Index of Ikai et al for a Hepatocellular Carcinoma with a Tumor Thrombus in a Major Portal Vein
- Modified Japan Integrated Scoring System (JISS) for a Patient with Hepatocellular Carcinoma
- Prognostic Factors of D'Antiga et al for a Patient with a Hepatoblastoma
- Milan Criteria for Liver Transplantation in a Patient with Cirrhosis and Small Hepatocellular Carcinomas
- University of California San Francisco (UCSF) Criteria for Liver Transplantation in a Patient with Cirrhosis and Small Hepatocellular Carcinomas
- Prognostic Model of Tateishi et al for Hepatocellular Carcinoma (Tokyo Score)
- Prognostic Factors of Liang et al for Survival Following Percutaneous Microwave Ablation of an Hepatocellular Carcinoma
- Pathological Score of Parfitt et al for Predicting Recurrent Hepatocellular Carcinoma Following Liver Transplantation
- Models of Yang et al for Predicting the Risk of Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B: Model A
- Models of Yang et al for Predicting the Risk of Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B: Model B
- Models of Yang et al for Predicting the Risk of Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B: Model C
- Invasiveness Score of El-Assal et al for Predicting Recurrence of a Hepatocellular Carcinoma After Curative Resection
- V-CLIP Scoring System of Kaseb et al for a Patient with Hepatocellular Carcinoma (HCC)
- Predictive Index for PVTT in HCC (PITH) of Yu et al.
- Score of Jun et al for Predicting Extrahepatic Metastasis in a Patient with Hepatocellular Carcinoma Following Curative Hepatectomy
- Diagnosis of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis Using the Serum Tumor Marker Score of Ramage et al
- TNM Staging System of Okabayashi et al for Intrahepatic Cholangiocarcinoma
- Classification of Bismuth and Corlette for Hilar Cholangiocarcinoma
- Criteria for Identifying an Intrahepatic or Perihilar Cholangicarcinoma as Unresectable
- Risk Factors for Carcinoma of the Gallbladder
- Prognostic Factors of Baton et al for Survival After Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 or 4 (Advanced Klatskin Tumor)
- Risk Factors of Shaib et al for Cholangiocarcinoma
- Prognostic Index of Park et al for Advanced Biliary Tract Adenocarcinoma
- Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma
- Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer
- Tumor Recurrence Prognostic Index (TRPI) of Hong et al for a Patient Following Liver Transplantation for Intrahepatic or Hilar Cholangiocarcinoma
- Prognostic Factors of de Jong et al for a Patient with an Intrahepatic Cholangiocarcinoma
- Model of Barr Fritcher et al for Evaluating a Patient with a Pancreatobiliary Stricture for the Risk of Malignancy
- Nomogram of Wand et al for a Patient with Intrahepatic Cholangiocarcinoma Following Partial Hepatectomy
- Prognostic Factors of Geer and Brennan in Patients with Pancreatic Adenocarcinoma
- Prognostic Index of Ikeda et al for Patients with Locally Advanced, Nonresectable Pancreatic Carcinoma
- Clinical and Laboratory Findings Associated with Poor Prognosis in Patients with Pancreatic Adenocarcinoma
- Management Options for a Patient with Pancreatic Adenocarcinoma
- Prognostic Index of Sawaki et al for a Patient with Metastatic Pancreatic Cancer Treated with Gemcitabine
- Contraindications for Attempting Surgical Resection of a Pancreatic Adenocarcinoma
- Cytologic Grading System of Eltoum et al for Pancreatic Adenocarcinoma
- Nomogram of Ferrone et al for Disease-Specific Survival After Resection of a Pancreatic Adenocarcinoma
- Risk Factors of Ferrone et al Associated with Survival in a Patient with Resectable Pancreatic Adenocarcinoma
- Histologic Grading System of Hruban and Fukushima for a Pancreatic Adenocarcinoma
- Histologic Features to Help Determining if Pancreatic Glands Are Benign or Malignant
- Criteria of Small et al for Response to Therapy in a Patient with a Pancreatic Cancer
- Risk Factors of Siddiqui et al for Early Mortality in a Male Military Veteran with Pancreatic Carcinoma
- Serum CA125 and CA19-9 in a Patient with Pancreatic Disease
- M.D. Anderson Criteria for Resectability of a Pancreatic Carcinoma
- McGill-Brisbane Symptom Score for Evaluating a Patient with Pancreatic Adenocarcinoma
- Prediction Rule of Cai et al for Estimating the Risk of Pancreatic Cancer in a Patient with Chronic Pancreatitis and a Focal Mass Lesion
- Adenosquamous Carcinoma of the Pancreas
- TNM Classification of Carcinoma Arising at the Ampulla of Vater
- Prognostic Factors of Kau et al for Periampullary Carcinomas
- Prognostic Factors of Carter et al for an Adenocarcinoma at the Ampulla of Vater
- Risk Factors in Rectal Carcinoid Tumors
- Indications for Hemicolectomy in a Patient with an Appendiceal Carcinoid Tumor
- Clinical Features of the Zollinger-Ellison Syndrome Associated with Neuroendocrine Gastrin Hypersecretion (Gastrinoma, Islet Cell Hyperplasia)
- Vasoactive Intestinal Peptide Secreting Tumor (VIPoma, Pancreatic Cholera, WDHA)
- Clinical Features of an Insulinoma
- Clinical Features of the Glucagonoma Syndrome
- Clinical Features of the Somatostatinoma Syndrome
- Clinical Features of the Carcinoid Syndrome
- Prognostic Factors of Shebani et al for Carcinoid Tumors Arising in the Gastrointestinal Tract
- Prognostic Classification of Hochwald et al for Pancreatic Endocrine Neoplasms
- Histologic Types of Solcia et al for Pancreatic Endocrine Tumors
- Criteria of Deshpande et al for a Malignant Pancreatic Endocrine Tumor
- TNM Staging Scheme of Ellison et al for Gastrinoma
- Prognostic Factors of Haider et al for a Patient with an Extrapulmonary Small Cell Carcinoma
- Histologic Grading Scheme of Rindi et al for a Foregut Neuroendocrine Tumor
- TNM Classification of Rindi et al for a Malignant Neuroendocrine Tumor Arising in the Pancreas
- Prognostic Factors of Ferrone et al for a Pancreatic Endocrine Neoplasm
- WHO Classification for Grading Pancreatic Endocrine Neoplasms
- Predictors of Capella et al for the Behavior of an Endocrine Tumor of the Stomach
- TNM Staging System of Landry et al for Appendiceal Carcinoid Tumors
- TNM Staging System of Landry et al for a Colonic Carcinoid Tumor
- Imaging Studies for Localizing a Neuroendocrine Tumor
- Risk Factors of Panzuto et al for Disease Progression for a Patient with a Pancreatic Endocrine Carcinoma
- Monitoring Serum Chromogranin A in a Patient with a Neuroendocrine Tumor
- Nomogram of Modlin et al for Predicting Survival in a Patient with a Neuroendocrine Tumor of the Small Intestine
- Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Criteria of Hough et al
- Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Criteria of Weiss
- Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Criteria of Slooten et al.
- Clinical and Pathologic Features Distinguishing Adrenocortical Tumors
- TNM Classification of Adrenal Cortical Carcinoma
- Predictors of Stojadinovic et al for Disease Specific Survival in Patients with Adrenocortical Carcinoma
- Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Modified Weiss Score of Aubert et al
- Histomorphological and Molecular Criteria of Stojadinovic et al for Metastatic Adrenocortical Carcinoma
- Algorithm of Blanes and Diaz-Cano for the Histopathologic Diagnosis of Proliferation Lesions of the Adrenal Cortex
- Staging Criteria of Sandrini et al for a Childhood Adrenocortical Tumor
- Fuhrman's Nuclear Grading System for Renal Cell Carcinoma
- Modified Staging System of Robson for Renal Cell Carcinoma
- TNM Staging System of the American Joint Committee on Cancer for Renal Cell Carcinoma
- Prognostic Factors for Renal Cell Carcinoma
- Prognostic Factors of Elson et al in Recurrent or Metastatic Renal Cell Carcinoma
- Prognostic Factors of Motzer et al in Advanced Renal Cell Carcinoma
- The UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma
- Prognostic Factors of De Forges et al for Patients with Metastatic Renal Cell Carcinoma
- Mathematical Model of Zisman et al for Predicting Survival in a Patient with Renal Cell Carcinoma
- Risk Group Analysis Algorithm of Zisman et al for Predicting Outcome in Patients with Surgically Resected Renal Cell Carcinoma
- Prediction Model of Leibovich et al for Patients with Clear Cell Renal Cell Carcinoma After Radical Nephrectomy
- SANI Score of Leibovich et al for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma After Nephrectomy and Immunotherapy with Interleukin-2
- Prognostic Factors of Motzer in Previously Treated Patients with Metastatic Renal Cell Carcinoma
- Prognostic Factors of Malhi et al for Patients with Metastatic Renal Cell Cancer
- Risk Score of Hanninen et al for a Patient with Metastatic Renal Cell Carcinoma
- Prognostic Score of Palmer et al for a Patient with Advanced Renal Cell Carcinoma Treated with Recombinant Interleukin-2
- The Stage, Size, Grade and Necrosis (SSIGN) Score of Frank et al for Predicting Survival in a Patient with a Clear Cell Renal Cell Carcinoma
- Postoperative Prognostic Model of Kattan et al for a Patient with Renal Cell Carcinoma
- Postoperative Model of Frank et al for Surveillance of a Patient with Clear Cell Renal Cell Carcinoma: Abdominal Recurrence Score
- Postoperative Model of Frank et al for Surveillance of a Patient with Clear Cell Renal Cell Carcinoma: Thoracic Recurrence Score
- Postoperative Model of Frank et al for Surveillance of a Patient with Clear Cell Renal Cell Carcinoma: Bone Recurrence Score
- Prognostic Model of Atzpodien et al for Patients with Metastatic Renal Cell Carcinoma
- Model of Yaycioglu et al for Recurrence Risk Following Resection in a Patient with Nonmetastatic Renal Cell Carcinoma
- Recurrence Risk Formula (RRF) of Cindolo et al for Predicting the Risk of Recurrence in a Patient with Nonmetastatic Renal Cell Carcinoma
- Prognostic Model of Donskov and von der Maase for a Patient with Metastatic Renal Cell Carcinoma
- Algorithm of Leibovich et al for Predicting Survival in a Patient with Metastatic Clear Cell Carcinoma of the Kidney (Mayo Clinic Score and Tumor Thrombus Level)
- Inflammation-Based Prognostic Score of Forrest et al for a Patient with Metastatic Renal Cancer (Glasgow Prognostic Score, GPS)
- Algorithm of Oesterling et al for Management of a Patient with a Renal Angiomyolipoma
- Algorithm of Liu et al for Distinguishing Different Types of Renal Cell Tumors Using Immunohistochemical Stains
- Staging System of Ficarra for Locally Advanced Renal Cell Carcinoma
- Nomogram of Lane et al for Chances of a Carcinoma in a Renal Tumor Removed By Partial Nephrectomy
- Nomogram of Lane et al for Chances of an Aggressive Carcinoma in a Renal Tumor Removed By Partial Nephrectomy
- Nomogram of Sorbellini et al for Predicting Recurrence After Resection of a Clear Cell Renal Cell Carcinoma
- Aggressive Phenotypic Features of Amin et al for a Chromophobe Renal Cell Carcinoma
- Diagnostic Features of a Chromophobe Renal Cell Carcinoma
- Risk Factors of Moudouni et al for Adrenal Metastases in a Patient with Renal Cell Carcinoma
- Prognostic Factors of Klatte et al for a Patient with a Clear Cell Renal Cell Carcinoma
- Prognostic Implications of a Paraneoplastic Elevation of Serum Alkaline Phosphatase in a Patient with Renal Cell Carcinoma
- Nomogram of Kutikov et al for Predicting Risk of Non-Cancer Death in a Patient with a Localized Renal Cell Carcinoma
- Nomogram of Kutikov et al for Predicting Risk of a Cancer Death in a Patient with a Localized Renal Cell Carcinoma
- Clinical and Pathologic Features of Renal Medullary Carcinoma
- Prognostic Factors of Cheng et al for a Patient with a Renal Medullary Carcinoma
- Prognostic Factors of Pichler et al for a Patient with Clear Cell Renal Cell Carcinoma
- Prognostic Factors of Pichler et al for a Patient with Papillary Renal Cell Carcinoma
- Predictors of Hudes et al for Poor Survival in a Patient with Metastatic Renal Cell Carcinoma
- RENAL Nephrotomy Score of Kutikov and Uzzo
- NWTS V Staging System for Wilms' Tumor
- TNM Staging for Wilms' Tumor
- Unfavorable Histologic Features in Wilms' Tumor
- Radiographic Findings of Brisse et al for Preoperative Rupture of a Wilms Tumor
- Histological and Cytological Grading of Urothelial Carcinomas
- Risk Factors of Cheng et al Affecting Survival in Patients with Cancer of the Urinary Bladder Treated By Radical Cystectomy
- Algorithm of Jarkrans et al for Classifying a Urothelial Bladder Cancer According to the Malmstrom Grading System
- Criteria for Response to Therapy in a Urothelial Carcinoma of the Urinary Bladder
- International Bladder Cancer Postoperative Nomogram of Bochner et al for Predicting Recurrence After Radical Cystectomy
- Staging System of Sheldon et al for Urachal Carcinoma
- Prognostic Index of Pomerance for a Carcinoma of the Urinary Bladder
- Pathologic Criteria of Sheldon et al for a Urachal Neoplasm
- Modified Staging System of Henly et al for Urachal Carcinoma (Mayo Staging System)
- Clinical Findings Associated with a Urachal Carcinoma
- Risk Factors Associated with Urothelial Carcinoma of the Urinary Bladder
- Postoperative Nomograms of Shariat et al for the Prognosis Following Radical Cystectomy for Bladder Cancer
- Algorithm of Margel for Predicting Pathologic Stage in a Patient with Organ-Confined Bladder Cancer by Clinical Evaluation
- Prognostic Factors of Bellmunt et al for a Patient with Metastatic Transitional Cell Carcinoma That Is Refractory to Platinum-Based Chemotherapy
- Nomogram of Jeldres et al for Predicting Survival for a Patient with an Upper Urinary Tract Urothelial Carcinoma
- TNM Classification and Staging for Carcinoma of the Vulva
- Risk Factors of Shah et al for Mortality in a Woman with Vaginal Cancer
- TNM and FIGO Classification and Staging for Carcinoma of the Cervix Uteri
- Histopathologic Score of Grisaru et al for Patients with Stage IA2, IB1 or IB2 Cervical Carcinoma
- Histopathologic Scores of Lai et al for Patients with Stage IB or II Cervical Carcinoma
- Histopathologic Risk Factors of Kamura et al for Women with Cervical Carcinoma
- Prognostic Factors of Sevin et al for a Woman with Early Cervical Carcinoma
- Risk Factors for Squamous Cell Carcinoma of the Cervix
- Histologic Grading System of Kristensen et al for the Invasive Front in a Squamous Cell Carcinoma of the Cervix
- Prognostic Factors of Kristensen et al for Early Squamous Cell Carcinoma of the Cervix
- Distinguishing Endocervical from Endometrial Adenocarcinoma
- Nomogram of Tseng et al for Predicting Survival of a Patient with Stage IIB to IVA Cervical Cancer
- Score of Biewenga et al for Survival in a Patient with Cervical Cancer
- Criteria for Squamous Differentiation and Malignancy in Endometrioid Adenocarcinoma
- Histologic Grading of Uterine Endometrioid Adenocarcinoma
- FIGO Staging for Uterine Corpus Carcinoma
- Prognostic Scores of Ambros and Kurman for Endometrioid Adenocarcinoma
- Risk Factors for Development of Endometrial Adenocarcinoma
- Pathological Models of Zaino et al for Predicting Outcome in Stage I and II Endometrial Adenocarcinoma
- A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma
- Grading System of Alkushi et al for Endometrial Carcinoma
- Pathologic Features of Scully et al for Malignant Tumors in Both the Endometrium and Ovary (Synchronous Primary vs Metastatic Carcinomas)
- Risk Factors of Soliman et al for Synchronous Endometrioid Carcinomas of the Endometrium and Ovary
- Risk Factors of Mariani et al for Lymph Node Metastasis in a Patient with Endometrial Carcinoma
- Risk Factors of Prat for Lymph Node Metastases in a Woman with Endometrial Carcinoma. Modified from Boronow et al
- Model of Todo et al for Predicting Lymph Node Metastases in a Woman with Endometrial Adenocarcinoma Based on Preoperative Risk Factors
- Risk Factors Associated with Route of Recurrence in a Woman with Endometrial Adenocarcinoma
- Risk Factors of Lampe et al for Pelvic Lymph Node Metastases in a Woman with Endometrial Adenocarcinoma
- Preoperative Factors of Kang et al for Identifying a Patient at Risk for Lymph Node Metastases from an Endometrial Adenocarcinoma
- Nomogram of Bendifallah et al for Predicting Lymph Node Metastases in a Woman with Stage I or Stage II Endometrial Cancer
- Histologic Diagnosis of Uterine Smooth Muscle Tumors
- Epithelioid Smooth Muscle Tumors of the Uterus
- Pathologic Diagnosis of Endometrial Stromal Tumors
- Prognostic Factors of Pautier et al for a Uterine Sarcoma
- Nomogram of Zivanovic et al for Predicting 5-Year Survival Following Resection of a Uterine Leiomyosarcoma
- TNM and FIGO Classifications for Cancer of the Fallopian Tubes
- p53 Signature in the Fallopian Tube of a Woman with a BRCA Mutation
- Scoring System of Schneider et al for Predicting Survival in Women with Advanced Ovarian Cancer
- CA125 Prognostic Score in Women with Ovarian Cancer
- Risk of Malignancy Index (RMI) of Jacobs et al for Ovarian Tumors
- Risk of Malignancy Index (RMI) of Tingulstad et al for Ovarian Tumors
- Ultrasound Scoring System of Sassone et al for Ovarian and Extrauterine Masses
- Screening Protocol of Jacobs et al for Ovarian Cancer Using CA125 and Ultrasound
- Ovarian Tumor Index of Twickler et al for Predicting the Risk of Malignancy
- CT Predictive Index of Bristow et al for Surgical Outcome in Women with Advanced Ovarian Carcinoma
- Histologic Grading System of Silverberg for Ovarian Epithelial Carcinomas
- Models of Timmerman et al to Distinguish a Benign and Malignant Adnexal Mass Before Surgery: Complex Model M1
- Models of Timmerman et al to Distinguish a Benign and Malignant Adnexal Mass Before Surgery: Simplified Model M2
- Prognostic Factors of Bell et al for a Patient with an Ovarian Serous Borderline Tumor and Peritoneal Implants
- Prognostic Index of Teramukai et al for Stage III or IV Epithelial Ovarian Cancer (PIEPOC)
- Histologic Grading of Immature Teratoma of the Ovary
- Prognostic Factors of Fox et al for a Woman with an Adult Granulosa Cell Tumor of the Ovary
- Prognostic Factors of Bjorkholm and Silfversward for a Woman with an Ovarian Granulosa Cell Tumor
- Two-Tier System of Malpica et al for Histologic Grading of an Ovarian Serous Carcinoma
- Sonographic Criteria of Patel et al for an Ovarian Cystic Teratoma (Dermoid Cyst)
- Risk Score of Chan et al for Relapse Free Survival for a Woman with an Epithelial Ovarian Cancer
- Estrogen Production By Ovarian Tumors
- Features of a Sex Cord Tumor with Annular Tubules Associated with Peutz-Jeghers Syndrome
- Differential Diagnosis of an Elevated Serum CA 125 (Cancer Antigen 125) Level
- Bowel Resection in a Woman with Ovarian Cancer
- Clinical Symptoms Associated with Ovarian Cancer
- Risk Factors of Dauplat et al for Distant Metastases in a Woman with an Epithelial Ovarian Carcinoma
- Indicators of von Gruenigen et al for Worsening Prognosis in a Woman with Ovarian Cancer
- Factors Identifying a Woman with Stage IV Ovarian Cancer Who May Benefit from Surgical Debulking
- Predictors of Funt et al for Tumor Resectability in a Woman with Recurrent Ovarian Cancer
- TNM and FIGO Staging of an Ovarian Carcinoma
- Risk for Ovarian Cancer in a Patient with Endometriosis
- Prognostic Factors of Fernandes et al for a Woman with Bowel Obstruction Secondary to Ovarian Cancer
- Prognostic Factors of Sharma et al for a Woman with Advanced Ovarian Cancer
- Score of Fagotti et al for Predicting Surgical Outcome in a Woman with Advanced Ovarian Cancer
- Sonographic Score of Tailor et al for Predicting the Risk of Malignancy in an Adnexal Mass
- Simple Ultrasound Rules of Timmerman et al to Decide If an Adnexal Mass Is Benign or Malignant
- Weighted Scoring System of Lerner et al for Evaluating an Ovarian Mass By Transvaginal Ultrasonography (Modified Sassone Score)
- Pulsatility Index (PI) in the Assessment of an Ovarian Neoplasm
- Predictors of Hata et al for Malignancy in a Patient with an Ovarian Tumor
- Logistic Model of Alcazar and Jurado for Predicting Malignancy in an Adnexal Mass
- Risk of Ovarian Malignancy Algorithm (ROMA) of Moore et al for Predicting an Epithelial Ovarian Cancer
- Prognostic Factors in Gestational Trophoblastic Disease
- WHO Prognostic Index Score for Gestational Trophoblastic Disease
- Staging of Gestational Trophoblastic Disease
- Brewer Score for Gestational Trophoblastic Disease
- Features Distinguishing Complete Mole, Partial Mole and Nonmolar Hydropic Change
- Indications of Sebire and Seckl to Give Chemotherapy to a Woman with Gestational Trophoblastic Disease
- Clinical Findings That May Be Presenting Features for Gestational Trophoblastic Disease
- Jewett (AUS) and TNM Staging of Prostate Carcinoma
- Prognostic Score of Pisansky et al for Clinically Localized Carcinoma of the Prostate
- Histologic Grading of Radiation Effect on Prostate Carcinoma
- Nomogram of Kattan et al for Prostate Cancer Recurrence Following 3D Conformal Radiation Therapy
- Clinical-Anatomic Staging System of Clemens et al for Prostatic Cancer
- Risk Analysis of Albertsen et al for Men Aged 55 to 74 Years at Diagnosis of Clinically Localized Prostate Cancer and Managed Conservatively
- Postoperative Nomogram of Kattan et al for Risk of Recurrence After Radical Prostatectomy for Localized Prostate Carcinoma
- Equation of Pisansky et al for Predicting the Likelihood of Metastases to Seminal Vesicles and/or Pelvic Lymph Nodes in a Patient with Prostate Cancer
- Nomogram of Smaletz et al for Predicting Survival in a Patient with Metastatic Prostate Cancer After Castration
- Nomogram of Kattan et al for Predicting 5 Year Probability of Metastasis Following Three Dimensional Conformal Radiation Therapy (CRT) for Localized Prostate Cancer
- Nomogram of Kattan et al for Preoperative Prediction of Being Recurrence Free at 5 Years Following Radical Prostatectomy for Prostate Cancer
- Equation of Lewis et al for the Total Volume of a Prostate Cancer Using the Extent of Tumor in Needle Biopsies and Serum PSA
- Prognostic Indices of Wilson et al for Patients with Advanced Prostate Cancer
- Models of Bostwick et al for Preoperative Prediction of Capsular Perforation and Seminal Vesicle Invasion in a Patient with Prostate Cancer
- Nomogram of Kattan et al for Preoperative Prediction of Biochemical Progression at 5 Years in Clinically Localized Prostate Cancer Using Interleukin-6 Soluble Receptor and Transforming Growth Factor B
- Criteria of Lara et al for the Response of Prostate Cancer to Therapy
- Score of Salomon et al for Predicting Pretherapeutic Seminal Vesicle Invasion in a Patient with Prostate Cancer
- Criteria of Epstein et al for Insignificant Prostate Carcinoma
- Classification and Regression Tree (CART) Analysis of Garzotto et al for Identification of a Man at High Risk for Prostate Carcinoma
- Probability of Prostate Cancer Specific Survival in a Patient with Biochemical Recurrence After Radical Prostatectomy Based on the Study of Freedland et al
- Equations of Roach for Extent of Prostate Carcinoma Based on Serum PSA Concentration and Gleason Score
- Criteria of Roach et al for Biochemical PSA Failure in a Patient with Prostate Cancer
- Nomograms of Karakiewicz et al for Predicting the Probability of Cancer in a Prostate Biopsy
- Nomogram of Halabi et al for Predicting Survival in a Man with Hormone Refractory Metastatic Prostate Cancer
- Postoperative Nomogram of Stephenson et al for Predicting Recurrence Free Survival After a Radical Prostatectomy
- Prognostic Model of Shulman and Benaim for Event-Free Survival (EFS) in a Man with Androgen-Independent Prostate Carcinoma
- Predictors of Zhou et al for Cancer-Specific Mortality in a Male with Recurrent Prostate Cancer
- Prognostic Scoring System of Buskirk et al for a Patient with Requiring Salvage Radiotherapy for Isolated PSA Increase After a Radical Prostatectomy
- The University of California San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) Scoring System
- Algorithm of Pound et al for Predicting the Chances of Being Free of Metastatic Disease Following Radical Prostatectomy for Prostate Cancer
- Proposed Prostate Cancer Staging System of Roach et al
- CART Model of Stephenson et al for Outcome Following Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
- Nomogram of Stephenson et al for Predicting the Probability of Progression Free Survival Following Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
- Model of Steyerberg et al for Prediction of Indolent Prostate Cancer
- CPDR/CaPSURE Postoperative Equation of Moul et al for Prostate Cancer Recurrence
- Nomogram of Nam et al for Predicting a Person's Risk of Having Prostate Cancer
- Nomogram of Kulkarni et al for Predicting the Chances of an Upgrade in a Patient's Initial Gleason Score After Histologic Review
- Model of Partin et al for Predicting Risk of Disease Recurrence Following Radical Prostatectomy
- Preoperative Risk Recurrence Equations of Bauer et al for a Patient Undergoing Radical Prostatectomy
- Nomogram of Nakanishi et al for Predicting a Low Grade and Low Volume Prostate Cancer
- Nomogram of Walz et al for Comparing 10 Year Survival Following Radical Prostatectomy vs Radiotherapy in a Man with Prostate Cancer
- Nomogram of Kattan et al for Predicting Survival in a Male with Clinically Localized Prostate Cancer That Is Managed Without Curative Intent
- Measuring the Length of Needle Core Biopsies and the Amount of Prostate Cancer Present
- Cytologic Features of Malignant Glands in a Patient with Prostate Adenocarcinoma
- Evaluating the Adequacy of Needle Core Biopsies from the Prostate for the Diagnosis of Prostate Cancer
- Histologic Patterns Seen at Low Power in a Prostate Biopsy
- Gleason's Histologic Grades of Prostatic Adenocarcinoma
- Predictors of Cheng et al for Survival in a Male with Prostate Cancer Following Radical Prostatectomy
- Determining the Gleason Score for a Male with Prostate Cancer
- Reporting the Secondary Pattern of a Prostate Cancer When Present in a Limited Amount Based on the 2005 ISUP Consensus Conference
- Recommendations of the 2005 ISUP Consensus Conference for Reporting the Gleason Score for a Patient with Prostate Cancer If a Tertiary Pattern is Present
- Risk Analysis of Gofrit et al for the Biopsy Gleason Score To Be Upgraded in the Prostatectomy Specimen
- Nomogram of Walz et al for Predicting Prostate Cancer in a Man with a Serum PSA Less Than or Equal to 2.5 ng/mL
- Vienna Nomogram for the Number of Prostate Core Biopsies
- Prognostic Index of Shamash et al for Predicting the Response of a Patient with Castrate-Resistant Prostate Cancer to Dexamethasone and Diethylstilbesterol Therapy
- Risk Categories of D'Amico et al for a Patient with Clinically Localized Prostate Cancer
- Quantitative Gleason Score of Reese et al for Improving Prostate Cancer Risk Assessment
- MRC 1993 Prognostic Factors for Metastatic Non-Seminomatous Testicular Germ Cell Tumors
- The International Germ Cell Cancer Collaborative Group (IGCCCG) Classification of Metastatic Germ Cell Cancer
- TNM Classification of Testicular Tumors
- Prognostic Score of Beyer et al for a Patient with Metastatic Germ Cell Tumor Treated By High Dose Chemotherapy and Hematopoietic Progenitor Cell Support
- Criteria for Response to Therapy in a Patient with a Germ Cell Tumor
- Indiana University Staging System for Testicular Cancer
- The Royal Marsden Hospital Classification for Testicular Cancer
- The Memorial Sloan-Kettering Mathematical Model for Risk in Patients with a Germ Cell Tumor
- Criteria of the German Testicular Cancer Study Group for Tumor Enucleation with Testicular Preservation in a Patient with Testicular Cancer
- Criteria of Browne et al for Intertubular Growth in a Pure Seminoma
- Prognostic Factors of Warde et al for Relapse in Stage I Seminoma Managed by Surveillance
- Pathologic Features of Balzer and Ulbright for Spontaneous Regression of a Testicular Germ Cell Tumor
- Prognostic Score of Einhorn et al for a Patient with a Metastatic Germ Cell Tumor
- Choriocarcinoma Syndrome in a Patient with Metastatic Nonseminomatous Germ Cell Tumor
- Growing Teratoma Syndrome (GTS)
- Equation of Steyerberg et al for Predicting Necrosis at Resection of Residual Masses of a Metastatic Nonseminomatous Germ Cell Tumor (NSGCT) After Chemotherapy
- Late Relapse of a Germ Cell Tumor
- Score of the International Prognostic Factors Study Group for a Patient with a Metastatic Germ Cell Tumor Who Has Failed First-Line Cisplatin-Based Chemotherapy
- Prognostic Factors of Fossa et al for a Patient with Testicular Cancer
- TNM Classification and Staging of Penile Carcinoma
- Risk of Disease Progression in Patients with Penile Squamous Cell Carcinoma Based on the Depth of Invasion and Vascular Invasion
- Risk Factors of Ficarra et al for Metastases to Nonpalpable Inguinal Lymph Nodes in a Patient with Squamous Cell Carcinoma of the Penis
- Prognostic Index (PI) of Cahilla et al for Predicting Metastases to Lymph Nodes in Squamous Cell Carcinoma of the Penis
- Nomogram of Kattan et al for Predicting Survival After Amputation for Penile Carcinoma Based on Clinical Stage and Pathologic Findings
- Nomogram of Kattan et al for Predicting Survival After Amputation for Penile Carcinoma Based on Pathologic Findings
- Classification of Jackson for Carcinoma of the Penis
- Prognostic Factors of Soria et al for a Patient with a Squamous Cell Carcinoma of the Penis
- Model of Thuret et al for Predicting Cancer-Specific Mortality (CSM) for a Male with Penile Cancer
- Scores of Taylor et al for Death and for Progression in Osteosarcoma
- Tumor Necrosis After Preoperative Chemotherapy in Osteosarcoma
- Enneking System for Staging Musculoskeletal Sarcomas
- TNM Staging of Osseous Malignant Neoplasms
- Grading Bone Tumors Based on Bone Destruction Pattern Seen on Radiographs
- Prognostic Factors in Osteosarcoma
- Histologic Grading Criteria of Evans et al for Conventional Chondrosarcoma of Bone
- Risk Factors of Fiorenza et al for a Patient with a Chondrosarcoma of Bone
- Grading Scheme of Tomita et al for Extension of a Sacral Osteosarcoma
- Classification Scheme of Tomita et al for Vertebral Tumors
- Model of Ferrari et al for Predicting Survival After Relapse With Lung Metastases in Osteosarcoma of the Extremities
- Criteria of Malawer for Limb-Sparing Resection of a Bone Tumor in an Extremity
- Histologic Grades of Gonzalez-Crussi et al for Sacrococcygeal Teratomas
- Prognostic Factors of Mialou et al for Pediatric Patients with Metastatic Osteosarcoma
- Prognostic Factors of Bacci et al for an Osteosarcoma of an Extremity Treated with Neoadjuvant Chemotherapy
- Risk Factors and Clinical Features for a Malignant Bone Tumor in a Patient with Paget's Disease of Bone
- Prognostic Factors of Longhi et al for an Elderly Patient with Osteosarcoma
- Surgical Classification of Malawer et al for a Shoulder-Girdle Resection of a Bone Tumor
- Dedifferentiation of a Chondrosarcoma
- Classification System of Malawer et al for Shoulder-Girdle Resection in a Patient with Sarcoma
- Histologic Grading Soft Tissue Sarcomas
- AJCC TNM Staging of Soft Tissue Sarcomas
- TNM Classification and Staging of Pediatric Soft Tissue Sarcomas
- Criteria of Bergh et al for Low and High Risk Groups in Patients with Synovial Sarcoma
- Prognostic Factors for Primary Localized Synovial Sarcomas of the Extremity
- Prognostic Model of Rooser et al for Patients with Soft Tissue Sarcoma
- Post-Operative Nomogram of Kattan et al for Predicting the Probability of Sarcoma-Specific Death at 12 Years After Surgery
- Prognostic Factors of Le Doussal et al for Localized Primary Malignant Fibrous Histiocytoma (MFH)
- Dutch and Memorial Sloan-Kettering Cancer Center Classification System for Retroperitoneal Soft Tissue Sarcoma
- The Histopathologic Grading System of the French Federation of Cancer Centers (FNCLCC) for Adult Soft Tissue Sarcoma
- Prognostic Staging System of Salo et al for a Malignant Fibrous Histiocytoma of an Extremity
- Prognostic Factors of Kilpatrick et al for Myxoid and Round Cell Liposarcomas
- Prognostic Factors of Behranwala et al for a Soft Tissue Sarcoma of the Buttock
- Prognostic Nomogram of Dalal et al for a Patient with a Primary Liposarcoma
- Prognostic Factors of Fiore et al for Myxoid, Round Cell and Pleomorphic Liposarcomas
- MRI Findings of Tateishi et al Associated with the Grade of a Myxoid-Round Cell Liposarcoma
- Classic Features of a Spindle Cell or Pleomorphic Lipoma
- Prognostic Factors of Palmerini et al for a Patient with a Synovial Sarcoma
- Using MDM2 and CPM Copy Numbers to Identify a Well-Differentiated Liposarcoma or Atypical Lipomatous Tumor
- Histologic Features of Canter et al for Predicting Survival in a Patient with a Soft Tissue Sarcoma
- Nomogram of Ardoino et al for Predicting Survival for a Patient with a Retroperitoneal Soft Tissue Sarcoma
- Grading System of Khoury et al for Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas
- Grading System of Parham et al for Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas (Pediatric Oncology Group Grading System for NRSTS)
- Benign Lesions That May Be Misdiagnosed as a Well-Differentiated Liposarcoma
- Criteria for a Lipoblast in the Diagnosis of Liposarcoma
- Prognostic Factors of Salas et al for a Desmoid Tumor
- Classification of Folpe and Weiss for an Ossifying Fibromyxoid Tumor (OFMT)
- Predictors of Abbott et al for Sarcoma-Specific Survival in a Patient with a Primary Retroperitoneal Sarcoma
- Risk Assessment Model of Demicco et al for a Patient with a Solitary Fibrous Tumor (SFT)
- Staging of Classic Kaposi's Sarcoma (Non-AIDS Associated)
- Staging of AIDS-Related Kaposi's Sarcoma
- Histologic Features Associated with Malignancy in Hemangiopericytoma
- Histologic Grades of Tang et al for Hemangiopericytoma of Bone
- Criteria of Folpe et al for Malignancy in a Glomus Tumor
- Prognostic Index of Stebbing et al for AIDS-Associated Kaposi's Sarcoma
- Clinical and Pathologic Features of a Splenic Angiosarcoma
- Risk Factors for Hepatic Angiosarcoma
- Prognostic Score of Naka et al for a Patient with an Angiosarcoma
- Criteria of Mena et al for an Anaplastic Hemangiopericytoma of the Central Nervous System
- Head-Tilt Test for a Cutaneous Vascular Neoplasm of the Head and Neck
- Clinical Features of Lymphangioleiomyomatosis (LAM)
- Diagnostic Critera of the European Respiratory Society (ERS) for Lymphangioleiomyomatosis
- Immunostaining for Human Herpesvirus 8 Latent Nuclear Antigen-1 (HHV-8 LNA-1) in the Diagnosis of Kaposi Sarcoma
- Pyogenic Granuloma-Like Kaposi Sarcoma
- Clinical Types of Kaposi Sarcoma (KS)
- Sites of Clinical Lesions in Endemic (African) Kaposi Sarcoma
- Rhabdomyosarcoma Score in Embryonal Rhabdomyosarcoma
- Prognostic Factors in Rhabdomyosarcoma
- Clinical Grouping Classification for Rhabdomyosarcoma
- Prognostic Factors of Carli et al for Children with Metastatic Rhabdomyosarcoma
- Failure Patterns in Rhabdomyosarcoma
- Prognostic Factors of Oberlin et al for a Patient with Metastatic Rhabdomyosarcoma
- Nomogram of Chisholm et al for Evaluating a Patient with Rhabdomyosarcoma in Relapse
- Diagnosis of Neurofibromatosis Type 1
- Clinical Risk Factors of Khosrotehrani for Mortality in Patients with Neurofibromatosis Type 1
- Prognostic Factors of Carli et al for Pediatric Malignant Peripheral Nerve Sheath Tumor (MPNST)
- Risk Factors of Needle et al for Progression of a Plexiform Neurofibroma
- Classification of Samii et al for a Jugular Foramen Schwannoma
- Elephantiasis Neuromatosa in Neurofibromatosis Type 1
- Clinical Stages of Jugulotympanic Paraganglioma (Glomus Jugulare Tumor)
- Pheochromocytoma of the Adrenal Gland Scaled Score (PASS)
- Prognostic Factors in Pelvic Ewing Sarcoma
- Prognostic Factors of Bacci et al for a Patient with Nonmetastatic Ewing Sarcoma of Bone Treated by Surgery and Adjuvant Chemotherapy
- Prognostic Factors of Rodriguez-Galindo et al for a Patient with Ewing Sarcoma (St. Jude Children's Research Hospital Risk Stratification Scheme)
- Prognostic Factors of Cotterill et al for a Patient with Ewing’s Sarcoma of Bone
- Prognostic Factors of Leavey et al for a Patient with Ewing Sarcoma at First Recurrence Following Multimodality Therapy
- Original and Modified Joshi Histologic Grading Criteria for Neuroblastomas
- TNM Classification of Neuroblastoma
- Clinical Staging of Neuroblastoma in Children Proposed By the Children's Cancer Study Group A
- Genetic Types of Neuroblastoma from Brodeur et al
- Prognostic Factors in Neuroblastoma
- Surgical Risk Factors (SRF) of Cecchetto et al in a Child with a Neuroblastoma
- Histologic Grading of Meningiomas
- Prediction of Poor Prognosis for Patients with Meningiomas
- Tumor Severity Score of Ziai to Describe Radiologic Features of a Brain Tumor
- Criteria of Ho for Anaplastic Ependymoma
- Prognostic Score of Pignatti et al for an Adult with a Low Grade Cerebral Glioma
- Prognostic Factors of Wong et al for a Patient with a High Grade Cerebral Glioma
- Response Criteria of Wong et al After Therapy for a High Grade Cerebral Glioma
- Prognostic Classes of Sarkaria et al for High Grade Malignant Gliomas
- Prognostic Score of Maillo et al for Patients with Meningioma
- Criteria of Ho et al for Predicting Recurrence of a Meningioma Based on Histopathology and the MIB-1 Labeling Index
- Prognostic Score of Salmon et al for an Adult with an Astrocytic Tumor
- Criteria of Eberhart et al for Describing the Histopathologic Features of a Medulloblastoma
- Staging Criteria of Chang et al for Medulloblastoma
- Prognostic Factors of Zeltzer et al in Patients Undergoing Therapy for Medulloblastoma
- Grades of Simpson for the Resection of a Meningioma Based on the Descriptions of Cairns et al
- Risk Factors of Ayerbe et al for Recurrence Following Resection of an Intracranial Meningioma
- Scoring System of Ayerbe et al for the Histologic Grading of a Meningioma
- Response Criteria of MacDonald et al Following Therapy for a Malignant Glioma
- Histologic Grading Criteria of Daumas-Duport et al for an Astrocytoma
- Histologic Grading Criteria of Burger and Vogel for an Astrocytoma
- Histologic Grading Criteria of Nelson et al for an Astrocytoma
- Model of Novotny et al for Predicting the Probability of Intracranial Edema Following Gamma Knife Surgery on a Meningioma
- Criteria of Taal et al for True vs Pseudo Progression Following Treatment of a Malignant Glioma
- Indications to Refer a Pediatric Patient for Assessment of a Possible Brain Tumor
- Risk Groups of Ellison et al for Childhood Medulloblastoma
- Classification of Pituitary Adenomas on Imaging Studies
- Indications for Surgical Resection of a Pituitary Adenoma
- Clinical Features of a Craniopharyngioma
- Risk Factors for Incomplete Resection of a Craniopharyngioma
- Factors of Roelfsema et al for Evaluating a Patient Following Surgery on a Pituitary Adenoma
- Predicting Growth of Small Choroidal Melanocytic Tumors Using the Risk Factors of Shields et al
- Classification of Reese and Ellsworth for Ocular Retinoblastoma
- Classification of the Childrens Cancer Group (CCG) for Extraocular Retinoblastoma
- Staging System of St. Jude Children's Research Hospital for Retinoblastoma
- Extraocular Tumors in a Patient with an RB1 Mutation (Secondary or Second Primary Tumors in Retinoblastoma)
- Regression Patterns in Ocular Retinoblastoma Following Radiation Therapy
- Predictors of Kaiserman et al for Conversion of a Choroidal Nevus to an Ocular Melanoma (Including the Combined KI Index)
- Risk Factors for Conjunctival Squamous Cell Carcinoma
- Clinical Features of Conjunctival Squamous Cell Carcinoma
- Prognostic Features of Khelfaoui et al for a Patient with Retinoblastoma
- 1997 TNM Classification and Staging of Skin Cancer
- Risk Factors for Recurrence and Metastasis in Squamous Cell Carcinoma of the Skin
- Risk Factors for Development of Squamous Cell Carcinoma of the Skin
- Staging System for Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin)
- Criteria of Folpe et al for Malignant Proliferating Trichilemmal Tumors (PTT)
- Recurrence Index Score of Rigel et al for Predicting Recurrent Basal Cell Carcinoma Following Mohs Surgery
- Risk Factors of Clayman et al for Mortality Associated with a Squamous Cell Carcinoma of the Skin
- Risk Factors of Veness et al for Lymph Node Metastases in a Patient with Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Prognostic Factors of Andrea et al for a Patient with a Merkel Cell Carcinoma
- N1S3 Staging System of Forest et al for Cutaneous Squamous Cell Carcinom of the Head and Neck with Lymph Node Metastases
- Risk Factors of Schwartz et al for a Positive Sentinel Lymph Node in a Patient with a Merkel Cell Carcinoma
- Prognostic Model of Soong for Malignant Melanoma
- Prognostic Model of Clark et al for Stage I Malignant Melanoma
- Grading Scheme of Spatz et al for Spitz Tumors in Children
- Predicting Mortality in Stage I Malignant Melanoma Using the Equations of Helfenstein et al
- Individualized Prognosis and Recurrence Risk Scores of Cochran et al for Patients with Malignant Melanoma
- Model of Vollmer et al for Predicting Pretest Probability of Metastatic Cutaneous Malignant Melanoma to Lymph Nodes
- Distance for Surgical Margins During the Excision of an Intermediate Thickness Primary Cutaneous Malignant Melanomas
- Prognostic Model of Schuchter et al for Predicting 10 Year Survival in Patients with Primary Melanoma
- Prognostic Model of Vollmer and Seigler al for Predicting 5 Year Survival in Patients with Cutaneous Malignant Melanoma
- The Revised AJCC TNM Staging System for Cutaneous Malignant Melanoma
- Prediction Scheme of Gamel et al for Predicting Survival in a Patient with Cutaneous Malignant Melanoma
- Prediction Scheme of Gamel et al for Predicting Conditional Probability of Cure at Followup in a Patient with Cutaneous Malignant Melanoma
- Prognostic Tree of Gimotty et al for a Patient with a Thin Primary Cutaneous Malignant Melanoma
- Risk Factors of Strouse et al for a Pediatric Patient with Malignant Melanoma
- Stringent Ultrasonographic Criteria for Diagnosis of Regional Lymph Node Metastasis from a Malignant Melanoma
- Recommended Margins for Wide Local Excision of a Primary Malignant Melanoma
- CART Model of Kruper et al for Predicting Sentinel Lymph Node Metastases in a Patient with AJCC Stage I or II Malignant Melanoma
- ABCDEF Rule of Levit et al for Detection of Subungual Melanoma
- Risk Factors Contributing to a Delay in Diagnosis of a Subungual Melanoma
- Risk for Melanocytic Proliferation and Malignant Melanoma Following Organ Transplantation, Chemotherapy or Immunosuppression
- Prognostic Index of Day et al for Cutaneous Melanoma and the Modified Prognostic Index of Schmid-Wendtner et al
- Prediction Model of Andtbacka et al for Metastatic Melanoma to a Nonsentinel Lymph Node in a Patient with Metastases to a Sentinel Lymph Node
- Risk Stratification of Schmoeckel et al for a Patient with Malignant Melanoma
- When to Refer a Pigmented Skin Lesion for Evaluation
- Ultrasonographic Criteria of Voit et al for Evaluating a Regional Lymph Node in a Patient with Malignant Melanoma
- Rotterdam Criteria for Classifying Metastases from a Malignant Melanoma in a Sentinel Lymph Node
- Risk Factors Associated with a Delay in the Diagnosis of a Malignant Melanoma
- N-SNORE Scoring System of Murali et al for Predicting Risk of Non-Sentinel Lymph Node Positivity for a Patient with Cutaneous Malignant Melanoma
- Hannover-II Scoring System for Classifying a Sentinel Lymph Node from a Patient with Malignant Melanoma
- Tumors Other Than Malignant Melanoma That May Contain Melanin Pigment
- Intracranial Hemorrhage Associated with Intracranial Metastases from a Malignant Melanoma
- Prognostic Factors in Sebaceous Carcinoma of the Eyelid
- Primary Cutaneous Adenoid Cystic Carcinoma (PCACC)
- Ultrastructural Length to Width Ratio of Microvilli in the Diagnosis of Mesothelioma
- TNM Classification of Pleural Mesothelioma
- Immunohistochemical Panels of Carella et al for Separating Epithelial Malignant Mesothelioma from Adenocarcinoma of the Lung
- Prognostic Score of Curran et al for Pleural Mesothelioma Based on the European Organization for Research and Treatment of Cancer (EORTC) Clinical Trials (EORTC Prognostic Score, EPS)
- Prognostic Groups of the Cancer and Leukemia Group B (CALGB) for Patients with Malignant Mesothelioma
- Risk Factors from the Cancer and Leukemia Group B (CALGB) Associated with Poor Prognosis in Patients with Malignant Mesothelioma
- Risk Factors of Metintas et al for Poor Prognosis in a Patient with Diffuse Malignant Pleural Mesothelioma
- Prognostic Factors of Bottomley et al for a Patient with Malignant Mesothelioma
- Immunohistochemical Panel of Abutaily et al for Distinguishing Malignant Mesothelioma and Pulmonary Adenocarcinoma
- Prognostic Index of Francart et al Predicting Survival for a Patient with Malignant Mesothelioma
- Histologic Features Distinguishing Mesothelioma from Atypical Mesothelial Hyperplasia
- Criteria of Bloss et al for Primary Peritoneal Serous Carcinoma
- Staging Peritoneal Carcinomatosis
- Gliomatosis Peritonei in a Patient with a Ventriculoperitoneal Shunt (VPS)
- Gliomatosis Peritonei in a Patient with a Teratoma
- Clinical Findings in a Patient with Pseudomyxoma Peritonei (PMP, Mucinous Ascites)
- Lesions That May Precede Pseudomyxoma Peritonei
- Histologic Classification of Pseudomyxoma Peritonei (PMP)
- Extent of Surgery Score (ESS) of Miner et al for a Patient with Pseudomyxoma Peritonei (PMP)
- Clinical Features of Pseudomyxoma Retroperitonei
- Changes of Pseudomyxoma Peritonei on Imaging Studies
- Criteria of Stoll and Crissey for Associating Development of a Malignancy with Preceding Trauma
- Diagnostic Criteria for Tuberous Sclerosis
- Diagnostic Criteria for the Muir-Torre Syndrome
- Clinical Features of Carney's Complex
- Clinical Features of Multiple Endocrine Neoplasia Type 1 (MEN1)
- Clinical Features of Multiple Endocrine Neoplasia Type 2A (MEN2A, Sipple Syndrome)
- Risk Groups for Medullary Carcinoma of the Thyroid in the MEN2 Syndrome Based on RET Testing
- Clinical Features of Multiple Endocrine Neoplasia Type 2B (MEN2B, MEN3)
- Classic Criteria for the Li-Fraumeni Syndrome (LFS)
- Criteria of Birch et al for a Li-Fraumeni Syndrome Like Family (LFL)
- Criteria of Chompret et al for Li-Fraumeni Syndrome
- Clinical Features of Von Hippel-Lindau Syndrome (VHL)
- Subtypes of Von Hippel-Lindau Syndrome (VHL) Based on Tumor Predilection
- Tubers and Other Intracranial Lesions of Tuberous Sclerosis Complex
- Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)
- Use of Immunohistochemistry to Identify the Primary Site of Metastatic Adenocarcinoma as Colonic versus Ovarian in Women
- Decision Tree to Distinguish Primary Ovarian Adenocarcinoma from Metastases to the Ovary from Colon or Breast
- Classification Rules to Distinguish Primary Ovarian Adenocarcinoma from Metastases to the Ovary from Colon or Breast
- Evaluating a Metastatic Carcinoma Using Immunohistochemical Stains for Cytokeratins 7 and 20
- Peritoneal Cancer Index (PCI) for Quantitation of Abdominal and Pelvic Metastases on CT Scan
- Predictive Factors of Bhattacharyya for Neoplasia and Malignancy in a Neck Mass
- Grading Extent of Disease (EOD) of Metastatic Tumor Involving Bone
- Evaluation of a Cancer Patient with Headache for Intracranial Metastases
- Risk Factors of Hirabayashi et al Affecting Survival After Palliative Surgery for Spinal Metastases
- Inflammatory Oncotaxis
- Algorithm of Hamaoka et al for the Diagnosis of Metastatic Breast Cancer to Bone
- Scoring System of van der Linden and the Dutch Bone Metastasis Study Group for Predicting Survival in Patients with Metastases to the Spinal Column
- Prognostic Scoring System of Tokuhashi et al for Preoperative Evaluation of a Patient with Metastases to the Spine
- Features of a Metastatic Poorly Differentiated Carcinoma from an Unknown Primary Site Potentially Responsive to Chemotherapy (Unrecognized Extragonadal Germ Cell Cancer Syndrome)
- Prognostic CART Analysis of Hess et al Starting with Lymph Node Status for a Patient with a Metastatic Carcinoma from an Unknown Primary
- Prognostic CART Analysis of Hess et al Starting with Liver Status for a Patient with a Metastatic Carcinoma from an Unknown Primary
- Scoring System of Tomita et al for Metastases to the Vertebral Spine
- Classification of Harrington for a Metastatic Periacetabular Fracture
- Radiographic Appearance of Common Carcinomas Metastatic to Bone
- Score of Mirels for Predicting the Risk of Pathologic Fracture in a Bony Metastasis
- Evaluation of a Patient with a Metastasis to the Umbilicus (Sister Mary Joseph's Nodule)
- Prognostic Score of Schindl et al for a Patient with Colorectal Cancer and Liver Metastases
- Clinical Findings Associated with Poor Prognosis in a Patient with Neoplastic Meningitis (Meningeal Carcinomatosis)
- Clinical Findings in a Patient with Neoplastic Meningitis (Meningeal Carcinomatosis)
- Recursive Partitioning Dendogram of Hess et al for Predicting the Primary Organ Site for a Metastatic Adenocarcinoma
- Prognostic Factors of Ogihara et al for a Patient with Lung Cancer Metastatic to the Spine
- Clinical Factors of Hosono et al Affecting Prognosis in a Patient with Spinal Metastases
- Prognostic Factors of Seve et al for a Patient with a Carcinoma of Unknown Primary Site
- Risk Factors of Seve et al for Survival and for Receiving Chemotherapy in a Patient with a Metastatic Carcinoma from an Unknown Primary Site
- Risk Factors for Malignant Pericardial Effusion
- Score of Van der Linden et al for Predicting Pathologic Fracture of the Femur (Modified Mirels Score)
- Prognostic Factors of D'Ambrosio and Agazzi for a Patient with a Brain Metastasis from an Unknown Primary
- Prognostic Score of Mizumoto et al for a Patient with Vertebral Metastases Treated with Radiation Therapy
- Criteria of Swenerton et al for Metastatic Breast Cancer to Bone and Response to Therapy
- Criteria of Swenerton et al for Metastatic Breast Cancer to the Bone Marrow and Response to Therapy
- Criteria of Swenerton et al for Metastatic Breast Cancer to the Pleura and Response to Therapy
- Prognostic Factors of Bruna et al for a Patient with Leptomeningeal Carcinomatosis
- Prognostic Factors of He et al for a Patient with Hepatocellular Carcinoma Metastatic to Bone
- Prognostic Factors of Mollet et al for a Patient with Skin Metastases from a Lung Carcinoma
- Clinical Features of a Subungual Metastasis
- Prognostic Factors of Lagerwaard et al for a Patient with Brain Metastases
- Prognostic Factors of Elias et al for a Patient with Peritoneal Carcinomatosis Associated with Colorectal Carcinoma
- Metastases to the Spleen
- Prognostic Factors of Jeong et al for a Patient Who Requires a Ureteric Stent for Malignant Ureteric Obstruction
- Carcinocythemia (Carcinoma Cell Leukemia)
- Graded Prognostic Assessment (GPA) of Sperduto et al for a Patient with Brain Metastases
- RTOG Recursive Partitioning Analysis (RPA) of Gaspar et al for Patients with Brain Metastases
- Prognostic Score of Le Scodan et al for a Woman with Breast Cancer Metastatic to the Brain
- Score Index for Radiosurgery (SIR) of Weltman et al for a Patient with Brain Metastases
- Prognostic Factors of Park et al for a Woman with Breast Cancer Metastatic to the Brain
- Score of Rades et al for Evaluating a Patient with Brain Metastases Treated By Whole Brain Radiotherapy
- Grading System of Ryu et al for Metastatic Epidural Compression About the Spinal Cord
- Prognostic Factors of Shuch et al for a Patient with a Brain Metastasis from a Renal Cell Carcinoma
- Extent of Pleural Carcinomatosis (EPC) Score of Rodriguez-Pandero and Lopez-Meijas
- Adrenal Hemorrhage Secondary to Metastasis from a Lung Cancer
- Algorithm of Brady et al for Identifying an Adrenal Metastasis in a Patient with Lung Cancer Based on PET/CT Findings
- Use of the Graded Prognostic Assessment (GPA) for a Patient with Brain Metastases from Malignant Melanoma or Renal Cell Carcinoma
- Use of the Graded Prognostic Assessment (GPA) for a Patient with Brain Metastases from a Breast Carcinoma
- Spinal Instability Neoplastic Score (SINS)
- Bone Scan Index (BSI) for Quantitation of Metastatic Tumor to Bone
- Institut Curie Prognostic Scores for Meningeal Carcinomatosis in a Woman with Metastatic Breast Cancer
- Differential Diagnosis of Cystic Metastases to the Brain
- Doxorubicin Pharmacokinetic Models of Ratain et al Using Limited Serum Sampling
- Estimating Carboplatin Clearance Using the Equation of Chatelut et al
- UICC Criteria for Tumor Response Following Therapy
- Grading Criteria of the Japan Society for Cancer Therapy for the Histopathologic Effect of Chemotherapy on a Solid Tumor
- Dosage Reduction for an Infusion of Alkeran (Melphalan hydrochloride)
- Dosage Reduction for Navelbine (Vinorelbine tartrate) for Hematologic and/or Hepatic Toxicity
- World Health Organization (WHO) Criteria for Tumor Response to Therapy
- Method of Warnke et al to Manage a Foul-Smelling Malignant Ulcer
- Conversion Factors of Le Deley et al for Doses of Alkylating Agents
- Conversion Factors of Le Deley et al for Doses of Anthracyclines
- Conversion Factors of Le Deley et al for Doses of Platinum Compounds and Epipodophyllotoxins
- Method of Loos et al for Fixed Dosing of Cisplatin Based on Body Surface Area
- Pharmacokinetic Test Dose of Bocci et al to Detect a Patient at Risk for Excessive Toxicity Prior to 5-Fluorouracil Therapy
- Method of Calvert et al for Dosing Carboplatin Based on Estimated Glomerular Filtration Rate (GFR)
- Formula of Schmitt et al for Estimating Carboplatin Clearance
- Formula of Thomas et al for Estimating Carboplatin Clearance
- Dosage Adjustment of Raymond et al for Irinotecan for a Patient with Colon Cancer and Hepatic Dysfunction
- Equations of Egorin et al for Calculating the Dose of Carboplatin Based on the Nadir Platelet Count
- Selection Criteria of Sandler et al for the Use of Bevacizumab with Paclitaxel-Carboplatin in a Patient with Lung Cancer
- Reasons Why a Patient with Lung Cancer May Not Respond to a Tyrosine Kinase Inhibitor (TKI) to Epidermal Growth Factor Receptor EGFR)
- Criteria of Kong et al for Metabolic Response to Therapy Seen on a PET Scan
- Prediction of Recurrence Following Hepatic Resection for Metastatic Colorectal Carcinoma Using the Clinical Score of Fong et al
- Selection of Patients with Recurrent Abdominal or Pelvic Sarcoma for Reoperation Using CT Scan Findings
- Selection of Patients with Mucinous Carcinomatosis of the Peritoneum for Reoperation Using CT Scan Findings
- Prognostic Score of Nordlinger et al for Patients with Surgical Resection of Metastatic Colorectal Carcinoma to the Liver
- Prognostic Score of Cady et al for Disease Free Survival After Hepatic Resection of Metastatic Colorectal Carcinoma
- WHO Criteria for Response of Metastatic Bone Lesions to Therapy
- UICC Criteria for Response of Metastatic Bone Lesions to Therapy
- Criteria of Hamaoka et al for Response of Metastatic Bone Lesions to Therapy
- Staging System of Minagawa et al for Evaluating a Patient with Liver Metastases from a Colorectal Cancer
- Criteria of Putnam for Resection of Pulmonary Metastases
- Prognostic Factors of Temeck et al for Reoperation to Resect Pulmonary Metastases in a Pediatric Patient with a Sarcoma
- Predictors of Adam et al for Complete Pathologic Response of Colorectal Metastases in the Liver Following Preoperative Chemotherapy
- Model of Iwatsuki et al for a Patient with Metastatic Colorectal Adenocarcinoma Undergoing Hepatic Resection (Pittsburgh Grades)
- Prognostic Factors of Rades et al for a Woman with Metastatic Breast Cancer Causing Spinal Cord Compression That Is Treated with Radiotherapy
- Monitoring the Response of a Patient with Colon Cancer Metastatic to the Liver Using Computer Tomographic (CT) Morphologic Groups
- Intraluminal Stents in the Management of a Woman with Stage IV Ovarian Carcinoma
- Predictors of Stephens et al for a Poor Outcome Following Pulmonary Metastasectomy in an Adult Patient with Sarcoma
- Criteria of Galsky et al That Make a Patient with Metastatic Urothelial Carcinoma Unfit for Cisplatin-Based Chemotherapy
- Preoperative Neutrophil to Lymphocyte Ratio and Other Predictors of Halazun et al for a Patient Undergoing Resection of Colorectal Metastases in the Liver
- Completeness of Cytoreduction Score (CC) of Sugarbaker and Chang for Peritoneal Carcinomatosis
- Palliative Prognostic Score for Staging Terminally Ill Cancer Patients
- Palliative Prognostic Index for Predicting Survival of Terminally Ill Cancer Patients
- Poor Prognosis Indicator of Bruera et al for Patients with Terminal Cancer
- Survival in Patients with Terminal Cancer Using Karnofsky Score and Key Symptoms
- Indicator of Morita et al for Predicting Survival in Terminal Cancer Patients
- The San Diego Severity Index (SDSI) for Patients with Terminal Cancer
- The Palliative Care Outcome Scale (POS)
- The Good/Bad/Uncertain (GBU) Index of Sloan et al for Predicting Survival in Patients with Advanced Cancer
- Prognostic Scores of Culine for Predicting Survival in Patients with Metastatic Carcinoma from an Unknown Primary Site
- Clinical Predictors of Vigano et al for Survival in Patients with Advanced Malignancy
- Model of Maltoni et al for Predicting Survival in a Patient with Terminal Cancer
- Prognostic Model of van der Gaast for Predicting Survival in a Patient with an Undifferentiated Carcinoma of Unknown Primary Site
- Prognostic Factors of Nathan et al for Survival in a Patient Requiring Surgery for a Pathologic Fracture
- Survival Prediction Score (SPS) of Chow et al in a Patient Receiving Palliative Radiotherapy
- Prognostic Factors of Gripp et al for Predicting Survival in a Terminally Ill Cancer Patient
- Prognostic Score of Barbot et al for a Patient with an Advanced Solid Tumor
- Models of Chow et al for Predicting Survival in a Patient with Advanced Cancer
- Survival Model of Rades et al for a Patient Undergoing Radiotherapy for Metastatic Spinal Cord Compression
- Prognostic Score of Arkenau et al for a Patient with a Malignant Neoplasm (Royal Marsden Hospital Prognostic Score)
- Bedside Score of Penel et al for Predicting 90 Day Mortality for a Patient with Cancer from an Unknown Primary
- Vitamin B12 to C-Reactive Protein (CRP) Ratio in a Patient with Advanced Cancer
- Model of Chiang et al for Predicting the Risk of Death within 7 Days of Hospice Admission for a Patient with Terminal Cancer
- Prognostic Score of Suh et al for Predicting Survival for a Patient with Terminal Cancer
- Predictors of Soubeyran et al for Early Death of an Older Adult Starting Cancer Chemotherapy
- Prognostic Models of Olmos et al for Phase I Clinical Trials in the European Drug Development Network (EDDN)
- Predictive Factors of Wray et al for Survival of Less Than 1 Month for a Patient with Hepatocellular Carcinoma
- Japanese Palliative Oncology Study Prognostic Index (JPOS-PI)
- Model of Ramchandran et al for Predicting 30-Day Mortality for a Cancer Patient in the Hospital
- Diagnosis Score of Lortholary et al for a Paraneoplastic Syndrome
- Hypoglycemia in Hemangiopericytoma and Other Nonendocrine Tumors
- Polycythemia (Erythrocytosis) Secondary to Erythropoietin Released from a Tumor
- Features of Paraneoplastic Necrotizing Myopathy
- Paraneoplastic Intestinal Pseudo-Obstruction
- Tumor-Associated Leukocytosis
- Tumor-Associated Thrombocytosis
- General Features of a Paraneoplastic Syndrome Involving Ectopic Hormone Secretion
- Processes That May Underly a Paraneoplastic Syndrome
- Different Tumor Histologic Appearances in Two Biopsies from a Patient with Cancer
- The Vanishing Cancer Phenomenon
- Carney Triad (Gastric Stromal Sarcoma, Pulmonary Chondroma, Paraganglioma)
- Prognostic Groups of Ang et al for Patients with Orophayrngeal Cancer Based on Human Papillomavirus (HPV), Smoking History and TNM Stage
- Classification of Weinberger et al for a Patient with Oropharyngeal Squamous Cell Carcinoma Based on Molecular Markers for Human Papillomavirus (HPV)
- Criteria of Mete and Asa for Vascular Invasion in a Follicular Carcinoma
- Score of Buffet et al for Predicting Recurrence for a Patient with a Papillary Thyroid Microcarcinoma
- Criteria of Buffet et al for Outcomes Following Therapy for a Papillary Thyroid Carcinoma
- Criteria of Watanabe et al for Diagnosing Large Cell Neuroendocrine Carcinoma (LCNEC) of the Lung in a Biopsy Specimen
- Differential Diagnosis of a Mediastinal Tumor Based on Its Location within the Mediastinum on Imaging Studies
- Nomogram of Mazouni et al for Predicting Survival for a Woman with Breast Cancer
- Immediate Breast Reconstruction Risk Assessment Score (IBRRAS) of Fischer et al
- Human Epidermal Growth Factor Receptor 2 (HER2) Testing by In Situ Hybridization (ISH) Using a Dual Probe Assay: 2013 ASCO/CAP Clinical Practice Guideline
- Human Epidermal Growth Factor Receptor 2 (HER2) Testing by Immunohistochemistry (IHC): 2013 ASCO/CAP Clinical Practice Guideline
- Reasons to Repeat HER2 Testing in a Patient with Breast Cancer
- Criteria of Vance et al for Genetic Heterogeneity (GH) in HER2 FISH Testing in Breast Cancer
- Equation of Flanagan et al for Approximating the Oncotype™ Recurrence Score (Original Magee Score)
- New Magee Equations for Predicting the Oncotype DX Recurrence Score for a Woman with Breast Cancer
- Scoring System of Lee et al for Predicting Lymph Node Metastases in a Patient with a T1 Esophageal Adenocarcinoma
- Criteria of Ushiku et al for Very Well-Differentiated Gastric Adenocarcinoma of the Intestinal Type
- Nomogram of Han et al for Predicting Long-Term Survival Following D2 Gastrectomy for Gastric Carcinoma
- Predictors of Chandrasinghe et al for Survival of a Patient with Rectal Carcinoma
- Nodal Staging Score (NSS) of a Goenen et al for a Patient with Node-Negative Colon Cancer
- Risk Factors of den Dulk et al for Adverse Outcomes in a Patient with Rectal Cancer Treated with an Abdominoperineal (AP) Resection
- Percentage of Stroma Within a Colon Cancer and Prognosis (Tumor-Stromal Ratio, Carcinoma-Stromal Ratio)
- Japanese Criteria for the Grading of a Renal Cell Carcinoma
- Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP)
- Nomogram of Galsky et al for Predicting Survival of a Patient with Advanced Urothelial Carcinoma
- Criteria of Nielsen et al for the Histologic Classification of a Smooth Muscle Tumor of the Vulva
- Hyperchromatic Crowded Groups (HCG) in Cytologic Preparations from a Patient with Endocervical Adenocarcinoma in Situ
- Problems Associated with Morcellation of a Uterus with an Unexpected Malignancy
- Model of AlHilli et al for Predicting Non-Home Discharge of a Woman with an Epithelial Ovarian Cancer Following Primary Surgery
- Prognostic Nomogram of Lee et al for Predicting Overall Survival for a Woman with Platinum-Sensitive Recurrent Ovarian Cancer
- Algorithm of Fisher et al for Managing a Patient with a Fatty Neoplasm
- Nomogram of Gronchi et al for Predicting Survival of a Patient with a Retroperitoneal Soft Tissue Sarcoma
- Staging Protocol of Weiss et al for Pediatric Rhabdomyosarcoma
- Fusion of PAX-FOXO1 Genes in Rhabdomyosarcoma (RMS)
- O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity and Response of a Glioblastoma to Temozolomide Therapy
- Modified RPA Prognostic Model of Li et al for a Patient with Glioblastoma Multiforme
- Prognostic Factors of Daniels et al for an Adult with a Low-Grade Glioma
- Placenta-Like Alkaline Phosphatase (PLAP) Associated with a Primary Intracranial Germinoma
- Features of Baxter et al of a High-Risk Basal Cell Carcinoma on the Face
- Indications for Mohs Surgery to Resect a Basal Cell Carcinoma on the Face
- Atypical Fibroxanthoma
- Brigham and Women's Hospital (BWH) Staging System for Cutaneous Squamous Cell Carcinoma
- 2009 UICC Staging System for Cutaneous Squamous Cell Carcinoma
- 2010 AJCC Staging System for Cutaneous Squamous Cell Carcinoma
- Staging Classification of Falch et al for Anorectal Malignant Melanoma (ARMM)
- Clark Levels for Cutaneous Malignant Melanoma
- Perianal Mucinous Adenocarcinoma Associated with a Chronic Anorectal Fistula
- Predictive Factors of Aaldriks et al for Deterioration of a Geriatric Patient Starting Chemotherapy
- Prognostic Factors of Naito et al for a Patient with Metastatic Renal Cell Carcinoma Following Removal of Metastases
- Prognostic Factors of Suh and Ahn for a Patient with Terminal Cancer
- Prognostic Score of Suh and Ahn for a Patient with Terminal Cancer
- Predictors of Partl et al for the Length of Survival for a Patient with Advanced Intra- and Extracranial Metastases from Malignant Melanoma
- Prognostic Factors of Shin et al for a Terminally-Ill Cancer Patient
- Neoplastic Fever (Cancer-Related Fever)
- Risk Factors of Deganello et al for Multiple Malignancies of the Head and Neck
- Yonsei Estimated Value (YEV) of Jeong et al for Predicting the Risk of a Lateral Neck Lymph Node Metastasis from a Papillary Thyroid Carcinoma
- LU-RADS (Lung Reporting and Data System) for Computed Tomography Screening
- Model of Liang et al for Predicting Survival of a Patient in China with a Resected Non-Small-Cell Lung Carcinoma (NSCLC)
- Molecular Classification of Zhang et al for Infiltrating Ductal Carcinoma Based on Immunohistochemical Staining
- Using Immunohistochemistry to Distinguish Between Usual and Atypical Ductal Hyperplasia of the Breast
- Prognostic Factors of Dawood et al for a Woman with an Inflammatory Carcinoma of the Breast
- Grading Criteria of Davison et al for a Mucinous Neoplasm of the Appendix
- High Risk Locations for Radiofrequency (RF) Ablation of an Hepatocellular Carcinoma (HCC)
- ALBI (Albumin-Bilirubin) Grade in a Patient with Hepatocellular Carcinoma
- Nomogram of Wang et al for Survival After Adjuvant Radiotherapy in a Patient with Gallbladder Cancer
- Nomogram of Wang et al for Survival Without Adjuvant Radiotherapy in a Patient with Gallbladder Cancer
- National Comprehensive Cancer Network (NCCN) Criteria for Resectability of a Pancreatic Cancer
- Carcinoid Crisis
- Lin-Weiss-Bisceglia (LWB) Criteria for Evaluating an Adrenocortical Oncocytic Tumor
- Contraindications for the Use of Bacillus Calmette-Guerin/Connaught (BCG) Therapy in a Patient with Urothelial Carcinoma of the Urinary Bladder
- Criteria of the IBCG for Progression in Nonmuscle Invasive Bladder Cancer
- Pelvic Masses Score (PMS) of Rossi et al for Evaluating a Pelvic Mass in a Woman
- Luteinized Thecomatosis of the Ovary Associated with Sclerosing Peritonitis
- Intratumoral Hemorrhage in a Vestibular Schwannoma (Acoustic Apoplexy)
- Sites Where Ectopic Pituitary Adenomas Can Occur
- Criteria of Lattes and Kessler for Metastasizing Basal Cell Carcinoma
- AEIOU Features of Heath et al for Diagnosing a Merkel Cell Carcinoma
- Nomogram of Maurichi et al for Predicting Survival of a Patient with a Thin Melanoma
- Regression in a Melanoma
- Simplified Peritoneal Cancer Index (SPCI) of the Netherlands Cancer Institute
- 7 Region Count for Peritoneal Cancer of the Netherlands Cancer Institute
- Familial Atypical Multiple Mole Melanoma (FAMMM)-Pancreatic Carcinoma Syndrome Associated with CDKN2A
- Risk Factors for Needle Track Seeding Following Needle Biopsy of a Hepatocellular Carcinoma
- Drop Metastasis
- Carcinoma Erysipeloides (Cutaneous Intralymphatic Metastases, Inflammatory Carcinoma, Metastatic Pseudocellulitis)
- Terminology of Metastases within Small Dermal Vessels (Carcinoma Erysipelatoides, Carcinoma Telangiectoides, Carcinoma Hemorrhagiectoides)
- Criteria for Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma (HCC)
- Reasons Why a Tumor May Be Resistant to an Alkylating Agent
- Levels of a Neck Dissection
- Radical and Modified Radical Neck Dissection (RND and MRND)
- Selective Neck Dissection (SND)
- Clinical Findings of Hui et al for Impending Death in a Patient with Advanced Cancer
- Revised Risk Classification of Frazier et al for Pediatric Extracranial Germ Cell Tumor
- Criteria for a Pathological Lymph Node on Ultrasonography
- Differential Diagnosis of a False Negative Biopsy of a Tumor
- Pathologic Features Distinguishing Primary from Metastatic Tumor
- Predictive Model of Guo et al for a Patient with Nasopharyngeal Carcinoma
- Nomogram of Zhang et al for Predicting Postoperative Recurrence in a Patient with Stage Ia Non-Small Cell Lung Carcinoma (NSCLC)
- PET/CT Volumetric Prognostic (PVP) Index of Zhang et al for a Patient with a Non-Small Cell Lung Cancer
- Pittsburgh Predictor of Wilson and Weissfeld for Lung Cancer Detection in a Screening Program
- Issues Associated with the Decision to Request a Contralateral Prophylactic Mastectomy (CPM)
- Predictors of Goldflam et al for Significant Histologic Findings in a Contralateral Prophylactic Mastectomy
- Nomogram of Albert et al for Predicting the Benefit of Radiation Therapy in an Older Woman with Breast Cancer After Conservative Surgical Resection
- Score of Halevy et al for Determining the Need for Relumpectomy in a Woman with Invasive Breast Cancer
- Aberrant Immunohistochemical Staining for CK7, CK20 and CDX2 in BRAF-Positive Colorectal Adenocarcinomas
- Total Mesorectal Excision (TME) Score of Quirke et al
- PDGFRA-Mutant Syndrome of Familial Gastrointestinal Stromal Tumors (GIST)
- Hepatoma Arterial-Embolisation Prognostic (HAP) Score of Kadalayil et al Predicting the Prognosis of a Patient with a Hepatocellular Carcinoma Treated with Transarterial Embolisation (TAE)
- Vienna Survival Model of Schoeniger-Hekele et al for Hepatocellular Carcinoma (VISUM-HCC)
- Nomogram of Agopian et al for Predicting Recurrence of Hepatocellular Carcinoma Following Liver Transplant
- Score of Wang et al for Predicting Recurrence of HBV-Associated Hepatocellular Carcinoma Following Liver Transplantation
- Neutrophil-to-Lymphocyte and Platelet-to_Lymphocyte Ratios for Predicting Outcome Following Transplant for Hepatocellular Carcinoma
- Paraneoplastic Syndromes Associated with Hepatocellular Carcinoma
- Prognostic Factors of Qu et al for a Patient with Hepatocellular Carcinoma
- Glypican-3 and Other Prognostic Factors of Shirakawa et al for a Patient with Hepatocellular Carcinoma
- Nomograms of Li et al for Survival After Resection of a Huge Hepatocellular Carcinoma: Preoperative Model
- Nomograms of Li et al for Survival After Resection of a Huge Hepatocellular Carcinoma: Postoperative Model
- Score of Heath et al for Cytologic Differentiation of Adenocarcinoma from Reactive Atypia in Bile Duct Brushings
- Algorithm of the International Association of Pancreatology (IAP) for Managing a Branch Duct Intraductal Papillary Mucinous Neoplasm (IPMN)
- Paraneoplastic Syndromes Associated with Renal Cell Carcinoma
- Clinical Findings in a Patient with Renal Cell Carcinoma
- Examination of the Renal Sinus in a Patient with Renal Cell Carcinoma
- Collins’s Law for Recurrence of Wilms Tumor and Other “Embryonic” Tumors (Collins Risk Period, CRP)
- Nomograms of Rose et al for Locally Advanced Cervical Cancer: 5-Year Overall Survival
- Nomograms of Rose et al for Locally Advanced Cervical Cancer: Prediction of Pelvic Recurrence
- Nomograms of Rose et al for Locally Advanced Cervical Cancer: Prediction of 2-Year Progression-Free Survival (PFS)
- Nomogram of Bendifallah et al for Predicting the Recurrence Risk for a Borderline Ovarian Tumor
- Criteria of Zargar-Shoshtari et al for Pelvic Lymph Node Dissection in a Patient with Penile Cancer
- Prognostic Factors Affecting Overall Survival in a Patient with Synovial Sarcoma (SS)
- Indications of Clay et al for MDM2 FISH Testing of a Lipomatous Tumor
- Madelung Disease (Multiple Symmetrical Unencapsulated Fat Deposits, Multiple Symmetrical Lipomatosis)
- CT Scoring System of Middleton et al for Desmoid Precursor Lesions in a Patient with Familial Adenomatous Polyposis
- Anatomic Classification of Benn et al for Pheochromocytoma and Paraganglioma
- Tumors Positive for Ewing Sarcoma Breakpoint Region 1 (EWSR1) Translocation
- Preoperative Prognostic Factors of Liang et al for a Patient with Glioblastoma Multiforme
- Prognostic Factors of Donato et al for a Patient with Glioblastoma Multiforme
- Prognostic Subclassification of Lyth for T1 Cutaneous Malignant Melanoma
- Risk Factors of Lam et al for Malignant Melanoma Occuring in a Patient with a History of CLL or SLL
- Placental Metastases
- Pseudomyxoma Cutis
- Prognostic Scores of Feldman et al for Men with Germ Cell Tumor Metastatic to the Brain: Score for Brain Metastasis Present at the Time of Initial Presentation
- Prognostic Scores of Feldman et al for Men with Germ Cell Tumor Metastatic to the Brain: Score for Brain Metastasis Present at Relapse
- Simplified Adjuvant Therapy Omission Risk Score of Datta et al for a Patient Following Resection of a Gastric Cancer
- Model of Sasaki et al for Predicting 5-Year Survival Following Resection of Hepatic Metastases from a Colorectal Adenocarcinoma
- Preoperative Prognostic Score of Malik et al for a Patient Undergoing Resection of Colorectal Liver Metastases
- Recommendations of Lin and DeAngelis for Treatment of Brain Metastases: Systemic Chemotherapy
- Recommendations of Lin and DeAngelis for Treatment of Brain Metastases: Surgery or Stereotactic Radiosurgery
- Recommendations of Lin and DeAngelis for Treatment of Brain Metastases: Whole Brain Radiation Therapy (WBRT)
- Stauffer Syndrome (Paraneoplastic Cholestasis or Hepatic Dysfunction)
- TNM Classification and Clinical Staging of Breast Carcinoma from the 7th Edition of the AJCC
- Nomograms of Van Zee et al for Predicting Additional Nodal Metastases in a Breast Cancer Patient with a Positive Sentinel Lymph Node: Without Frozen Section
- Nomograms of Van Zee et al for Predicting Additional Nodal Metastases in a Breast Cancer Patient with a Positive Sentinel Lymph Node: With Frozen Section
- Differential Diagnosis of Signet Ring Cells in a Histologic Section
- Staging System of Dahlstrom et al for a Patient with HPV-Related Oropharyngeal Cancer
- HPV-Related Pure and Mixed Neuroendocrine Carcinomas of the Oropharynx
- Prognostic Models of Zeng et al for a Patient with a Nasopharyngeal Carcinoma: Model for Distant Metastasis-Free Survival (DMFS)
- Prognostic Models of Zeng et al for a Patient with a Nasopharyngeal Carcinoma: Model for Disease-Specific Survival (DSS)
- Prognostic Models of Zeng et al for a Patient with a Nasopharyngeal Carcinoma: Model for Local Recurrence-Free Survival (LRFS)
- Risk Factors of Dedivitis et al for Pharyngocutaneous Fistula (PCF) After Total Laryngectomy
- Nomogram of Lang et al for Predicting 10-Year Disease-Specific Death in a Patient with Papillary Thyroid Carcinoma
- Nomogram of Lang et al for Predicting 10-Year Disease Recurrence in a Patient with Papillary Thyroid Carcinoma
- Predictive Factors of Petric et al for Malignancy in a Follicular Neoplasm of the Thyroid
- Monitoring a Patient for Recurrent Thyroid Cancer with Thyroglobulin and Other Monitoring a Patient with Thyroid Cancer for Recurrent Disease Using Thyroglobulin and Other Markers
- Model of Evison et al for Predicting Malignancy in Lymph Nodes Diagnosed as Negative on EBUS-TBNA
- Prognostic Score of Zhu et al for a Patient with Non-Small Cell Lung Carcinoma (NSCLC) Based on the Systemic Inflammatory Response (SIR)
- Superior Mediastinum Syndrome (SMS)
- Clinical Signs and Symptoms Which May Indicate the Presence of a Cardiac Tumor
- Familial Atrial Myxoma Syndrome
- Clinical and Laboratory Findings Associated with an Atrial Myxoma
- Ultrasonographic Features of an Atrial Myxoma
- Risk Factors for Recurrent Atrial Myxoma
- Clinical Findings Associated with a Papillary Fibroelastoma
- Clinical Features of a Cardiac Rhabdomyoma
- Clinical and Pathologic Features of a Cardiac Fibroma
- Clinical and Pathologic Features of a Cardiac Angiosarcoma
- University of Southern California/Van Nuys Prognostic Index for Ductal Carcinoma in Situ (DCIS) of the Breast
- Prognostic Score of Smith et al for Ductal Carcinoma in Situ (DCIS) of the Breast
- Typical and Atypical Symptoms of Koo et al in Women with Breast Cancer
- Nomogram of Sudo et al for Predicting Distant Metastases After Multimodality Therapy for a Patient with Localized Esophageal Cancer
- C-Reactive Protein (CRP) to Albumin Ratio and Prognosis in a Patient with Operable Squamous Cell Carcinoma of the Esophagus
- Prognostic Score of Deans et al for a Patient with Gastro-Esophageal Cancer
- Asia-Pacific Colorectal Screening (APCS) Score of Yeoh et al
- Nomogram of Cheung et al for Identifying a Patient with Colon Cancer Who Is at Risk for Early Mortality
- Score of Imperiale et al for Risk of Advanced Colorectal Neoplasia in an Asymptomatic Adult
- Prognostic Factors of Harris et al Following Palliative Resection of a Colorectal Carcinoma
- Metachronous Advanced Colorectal Neoplasm Prediction Scoring (MAPS) Model of Lee et al
- Risk Factors of Park et al for Endoscopic Screening of a Patient for Advanced Proximal Colon Neoplasm
- Prognostic Nomogram of Hsu et al for the Barcelona Clinic Liver Cancer System for a Patient with Hepatocellular Carcinoma
- STATE Score of Hucke et al for a Patient with Hepatocellular Carcinoma
- ART Score of Sieghart et al for a Patient with Hepatocellular Carcinoma
- Up-to-Seven Criteria of Mazzaferro et al for Liver Transplantation in a Patient with Hepatocellular Carcinoma (HCC)
- Risk Factors of D’Amico et al for Recurrent Hepatocellular Carcinoma Following Liver Transplant
- Post-Resection Independent Predictive (PRIP) Score of Hung et al for Recurrence of Hepatocellular Carcinoma Associated with Hepatitis B Virus (HBV)
- Criteria of Khorana et al and the American Society of Clinical Oncology (ASCO) for Potentially Curable Pancreatic Cancer
- Preoperative Prognostic Score (PPS) of Miura et al for a Patient with Locally Advanced Pancreatic Body Cancer After Distal Pancreatectomy and Celiac Axis Resection (DP-CAR)
- Prognostic Factors of Marulli et al for a Patient with a Primary Chest Wall Chondrosarcoma
- Models of Wang et al for a Patient with an Extremity Osteosarcoma: Model for 5-Year Lung Metastasis Free Survival
- Models of Wang et al for a Patient with an Extremity Osteosarcoma: Model for 5-Year Overall Survival
- Prognostic Factors of Singer et al for a Patient with Retroperitoneal Liposarcoma
- Clinical and Pathologic Findings in Dedifferentiated Liposarcoma
- Criteria for Identifying a Malignant Granular Cell Tumor
- Prognostic Factors of Wushou et al for a Head and Neck Hemangiopericytoma
- Angioglioma
- Recursive Partitioning Analysis (RPA) of Scott et al for a Patient >= 70 Years Old with Glioblastoma
- Clinical Presentation of a Patient with Diffuse Intrinsic Pontine Gliome (DIPG)
- Score of Jansen et al for Predicting 12-Month Mortality for a Child with a Diffuse Intrinsic Pontine Glioma (DIPG)
- Risk Factors of Verlut et al for Poor Overall Survival for a Patient with Glioblastoma Multiforme Receiving Chemoradiotherapy
- Clinical Features of an Intracranial Teratoma (Germinoma) Arising in the Suprasellar Region
- MEL (Melanoma) Scoring System for PD-L1 Expression in Malignant Melanoma
- Multiple Endocrine Neoplasia 4 (MEN4) Syndrome
- Metastasis to a Percutaneous Endoscopic Gastrostomy (PEG) Site
- Revised Prognostic Scoring System of Tokuhashi et al for Preoperative Evaluation of a Patient with Metastases to the Spine
- Clinical Findings Associated with Metastatic Carcinoma to the Heart
- Staging System of Nagashima et al for Metastatic Colorectal Carcinoma to the Liver
- Factors of Chung et al Associated with Favorable Salvage Surgery of a Recurrent Squamous Cell Carcinoma of the Head and Neck
- Score of Rades et al for Identifying a Patient with Metastatic Spinal Cord Compression with Short Life Expectancy
- Staging System of Lee et al for M0 Oral Cancer
- Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
- Preoperative Endocrine Prognostic Index (PEPI) of Ellis et al for a Woman with Breast Cancer
- Clinical Score of Oliphant et al Predicting Cancer-Specific Survival for a Patient with Stage II Colon Cancer
- NSP Score of Zhang et al for Evaluating a Patient with Intermediate Stage Hepatocellular Carcinoma
- MORAL Scores of Halazun et al for Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplant
- Predictors of Muszynska et al for Incidental Gallbladder Cancer in a Patient Undergoing Cholecystectomy for Benign Disease
- Clinical Findings That May Indicate the Presence of Cholangiocarcinoma in a Patient with Hepatolithiasis
- Clinical Score of Tran et al for Long-Term Survival After Repeat Resection of a Recurrent Adrenocortical Carcinoma
- Predictors of Gershman et al for 1-Year Metastasis-Free Survival (MFS) Following Surgery for Renal Cell Carcinoma (RCC)
- Predictors of Gershman et al for Mortality Following Surgery for Renal Cell Carcinoma (RCC)
- Rajavithi-Ovarian Cancer Predictive Score (R-OPS) of Yanaranop et al
- Classification of Craniopharyngioma on Sagittal MRI Imaging
- Multimodality Prognostic Score (MMPS) of Opitz et al for a Patient with a Malignant Pleural Mesothelioma
- Primary Pericardial Mesothelioma
- Prognostic Score of Perri et al for a Woman with Metastatic Gynecologic Cancer and Malignant Bowel Obstruction
- Late Chemotherapy
- Indications of Cummins et al for Palliative Surgery in a Patient with Metastatic Colorectal Carcinoma
- Prognostic Scale of Chuang et al for Survival in a Patient with Terminal Cancer in Taiwan
- Chinese Prognostic Scale (ChPS) of Lingjun et al Predicting Survival in Chinese Patients with Advanced Cancer
- Prognostic Factors of Bachelot et al for a Patient with Advanced Cancer in a Phase I Clinical Trial
- Modified Palliative Prognostic Score of Scarpi et al with Addition of Delirium Assessment in a Patient with Terminal Cancer
- Nomogram of Feliu et al for a Patient with Terminal Cancer
- Palliative Prognostic Score of Kurashima et al for a Terminally-Ill Pediatric Patient with Cancer
- Risk Model of Huang et al for Predicting Survival in a Patient with Carcinoma of Unknown Primary Site
- Predictors of Wright et al for Survival in a Patient with Incurable Stage IV Cancer and Malignant Bowel Obstruction
- Signs and Symptoms of Occult Malignancy
- Score of Martinez-Gimeno et al for Predicting Lymph Node Metastases in a Patient with Squamous Cell Carcinoma of the Oral Cavity
- Predictors of Bhattacharyya and Fried for Lymph Node Metastases from a Carcinoma or Sarcoma Arising in a Major Salivary Gland
- Staging of an Anaplastic Thyroid Carcinoma According to the 8th Edition of the AJCC Staging Manual
- Staging of a Differentiated Thyroid Carcinoma According to the 8th Edition of the AJCC Staging Manual
- TNM Coding for a Thyroid Carcinoma from the 8th Edition of the American Joint Commission on Cancer (AJCC) Staging Manual
- HAL Model of O'Connell et al for Prediction of Lymph Node Metastasis in Lung Cancer
- Prognostic Factors of Toyokawa et al for a Patient with Resectable Thoracic Esophageal Squamous Cell Carcinoma
- Product of Serum Alpha-Fetoprotein and PIVKA-II for Prediction of Aggressive Behavior in an Early Stage Hepatocellular Carcinoma (HCC)
- T-Stage Classification of Jarnagin et al for Hilar Cholangiocarcinoma (Blumgart Preoperative Staging System for Hilar Cholangiocarcinoma)
- Findings of Gaujoux and Mihai Associated with an Adrenocortical Adenocarcinoma in a Patient with an Adrenal Mass
- Risk Factors of Gaujoux and Mihai for Recurrence of an Adrenocortical Adenocarcinoma After Surgery
- Risk Factors of Haisma et al for Lymph Node Metastases in a Patient with a Squamous Cell Carcinoma of the Skin from the Head and Neck
- Risk Factors of Asgari et al for Squamous Cell Carcinoma of the Skin in an HIV-Positive Patient with a History of Nonmelanoma Skin Cancer (NMSC)
- Prognostic Factors for Anorectal Malignant Melanoma
- Prognostic Factors of Sangisetty and Miner for a Patient with Malignant Ascites
- Nomogram of Renfro et al for Predicting 90-Day Mortality for a Patient with Metastatic Colorectal Carcinoma
- RULE of Scully for Early Recognition of Oral Cancer
- Endobronchial Ultrasound (EBUS) Scoring System of Schmid-Bindert et al for Predicting Metastatic Cancer to Mediastinal Lymph Nodes
- Histological Score and Classification Tree of McCallum et al for a Woman with Node-Negative Breast Cancer
- Nomogram of Eom et al for Survival After Gastric Cancer Surgery
- BALAD Score of Toyoda et al for Staging Hepatocellular Carcinoma
- Conventional Japanese Integrated Staging (JIS, c-JIS) Staging System of Judo et al for a Patient with Hepatocellular Carcinoma
- LCSGJ (Liver Cancer Study Group of Japan) TNM Classification for Hepatocellular Carcinoma
- Biomarker-Combined Japanese Integrated Staging (bm-JIS) Staging System of Kitai et al for a Patient with Hepatocellular Carcinoma
- GALAD Score of Johnson et et al for the Diagnosis of Hepatocellular Carcinoma
- Hong Kong Staging Classification for Liver Cancer (HKLC) of Yau et al
- Nomogram of Liu et al for Recurrence of an Early Hepatocellular Carcinoma After Radiofrequency Ablation (RFA)
- Advanced Liver Cancer Prognostic System (ALCPS) of Yau at al
- NIACE Score of Adhoute et al for Predicting Overall Survival in a Patient with Advanced Hepatocellular Carcinoma
- Taipei Integrated Scoring (TIS) System of Hsu et al for a Patient with Hepatocellular Carcinoma
- Total Tumor Volume (TTV) of the Taipei Integrated Scoring (TIS) of Hsu et al for a Patient with Hepatocellular Carcinoma
- Sorafenib Advanced HCC Prognosis (SAP) Score of Edeline et al for a Patient with Advanced Hepatocellular Carcinoma
- ABCR Score of Adhoute et al for a Patient with Hepatocellular Carcinoma
- Prognostic Score of Tournoux-Facon et al for a Patient with Advanced Hepatocellular Carcinoma
- CLIP Score Plus Performance Status for a Patient with Advanced Hepatocellular Carcinoma
- BALAD-2 Score of Fox et et al for Determining Prognosis for a Patient with Hepatocellular Carcinoma
- Modified Barcelona Clinic Liver Cancer (BCLC) System of Chan et al with Integration of the Albumin-Bilirubin (ALBI) Score for a Patient with Hepatocellular Carcinoma
- Treatment Guidelines of the Asian Pacific Association for the Study of the Liver (APASL) for a Patient with Hepatocellular Carcinoma
- Modified Hepatoma Arterial Embolization (mHAP) Score of Pinato et al for Predicting Survival for a Patient with Hepatocellular Carcinoma
- Risk Factors of Trivedi et al for Hepatocellular Carcinoma Arising in a Patient with Primary Biliary Cholangitis (PBC)
- 2005 Japanese Treatment Algorithm for a Patient with Hepatocellular Carcinoma
- Scoring System of Yang et al for Selecting a Patient with Hepatocellular Carcinoma for Living Donor Liver Transplantation
- Classification of Shi et al for Malignant Thrombus in the Portal Vein Associated with Hepatocellular Carcinoma
- Prognostic Score of Shen et al for a Patient with a Solitary Large Hepatocellular Carcinoma
- Preoperative Risk Score of Sasaki et al for a Patient with Intrahepatic Cholangiocarcinoma
- Extrarenal Wilms' Tumor (ERWT)
- Prognostic Factors of Nathan et al for a Patient with a Primary Retroperitoneal Sarcoma
- Classification of Shamblin et al for Carotid Body Tumor (CBT, Cervical Paraganglioma)
- Clinical Findings Associated with a Carotid Body Tumor (CBT, Cervical Paraganglioma)
- Risk Factors of Kim et al for Complications After Resection of a Carotid Body Tumor (CBT, Cervical Paraganglioma)
- Clinical Features of a Vagal Paraganglioma (VP)
- Diffuse Melanosis Cutis (DMC) Associated with Metastatic Malignant Melanoma
- Predictive Model of Ohn et al for the Diagnosis of Subungual Melanoma in Situ
- Metastatic Carcinoma to the Nasal Tip
- LENT Score of Clive et al for Predicting the Prognosis of a Patient with a Malignant Pleural Effusion
- Oswestry Spinal Risk Index (OSRI) of Balain et al
- PROMISE Model of Psallidas et al for a Patient with Malignant Pleural Effusion: Clinical Score
- PROMISE Model of Psallidas et al for a Patient with Malignant Pleural Effusion: Biochemical Score
- Prognostic Factors of Yang et al for Postoperative Survival in a Patient with Spinal Metastases
- Score of Bauer and Wedin for a Patient with Spinal and Extremity Metastases
- Lymph Node Ratio (LNR)
- PD-L1 Combined Positive Score (CPS)
- Risk Factors of Kuo et al for Disease-Specific Mortality Associated with Medullary Carcinoma of the Thyroid Gland
- Lung Cancer Arising in a Lung Transplant Recipient
- Clinical Prediction Rule of Shafazand and Gould for Mediastinal Metastasis from a Non-Small Cell Lung Cancer (NSCLC)
- Risk Factors of Visser et al for Invasive Breast Carcinoma Following Resection of an Ipsilateral Ductal Carcinoma in Situ (DCIS)
- Nomogram of Lee et al for Gastric Cancer Associated with Peptic Ulcer Disease in Taiwan
- eCura System of Hatta et al for Curability of Early Gastric Cancer After Endoscopic Submucosal Dissection
- HCC-MELD Score of Freeman et al
- Nomograms of Fu et al for a Patient with Hepatocellular Carcinoma and without Portal Vein Tumor Thrombosis After Curative Resection: Overall Survival
- Nomograms of Fu et al for a Patient with Hepatocellular Carcinoma and without Portal Vein Tumor Thrombosis After Curative Resection: Recurrence-Free Survival (RFS)
- Albumin to Alkaline Phosphatase Ratio in a Patient with Cholangiocarcinoma
- Asbestos-Related Cholangiocarcinoma
- Fibrinogen-to-Albumin Ratio (FAR) and Other Prognostic Factors of Xu et al for a Patient with Gallbladder Cancer
- Prognostic Score of Schweitzer et al for a Biliary Tract Cancer
- Risk Factors of Lazaryan et al Afffecting Overall Survival of a Patient with an Ampullary Adenocarcinoma
- Nomograms of Cao et al for Predicting Survival of a Patient with a Gastric Neuroendocrine Carcinoma (NEC)
- Nomogram of Kim et al for Recurrence-Free Survival (RFS) After Curative Resection of an Adrenocortical Carcinoma
- Nomogram of Kim et al for Overall Survival (OS) After Curative Resection of an Adrenocortical Carcinoma
- Adrenal Cortical Carcinoma Prognostic Score of Freire et al
- Predictors of Sahovaler et al for Outcome in a Patient with Cutaneous Squamous Cell Carcinoma of the Head and Neck with Regional Lymph Node Metastases
- Staging System of Breuninger et al for Cutaneous Squamous Cell Carcinoma
- Visceral Crisis in Metastatic Cancer
- Modified Bauer Score of Leithner et al for a Patient with a Spinal Metastasis
- Prognostic Factors of Sioutos et al for a Patient with Spinal Metastases
- ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)
- Prognostic Index of Sundaresan et al for Identifying a Lung Cancer Patient with Multiple Brain Metastases Who May Have an Early Death and Not Benefit from Whole Brain Radiotherapy
- Nuclear-to-Cytoplasmic Ratio (NCR)
- Histopathologic Score of Nason et al for Squamous Cell Carcinoma of the Floor of the Mouth
- Model of Cecatto et al for Pharyngocutaneous Fistula After Laryngectomy for Cancer
- Prognostic Score of Silva-Figueroa et al for Parathyroid Carcinoma
- Laboratory Prognostic Index of Ulas et al for a Patient with Non-Small Cell Lung Cancer (NSCLC)
- Prognostic Index of Kasymjanova et al for a Patient with Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Clinical Prognostic Score of Gong et al for a Patient with Advanced Non-Small Cell Lung Cancer (NSCLC)
- Prognostic Score of Trape et al for Advanced Non-Small Cell Lung Cancer (NSCLC)
- Montreal Prognostic Score (MPS) of Gagnon et al for Advanced Non-Small Cell Lung Cancer (NSCLC)
- Clinical Prediction Rule of Galvin et al for Female Breast Cancer
- Histopathologic Prognostic Score of Zhu et al for Gastric Carcinoma
- Recommendations for Continuing Surveillance of a Patient Diagnosed with Colon Cancer
- Predictors of Dumont et al for a Positive Circumferential Margin Following Chemoradiotherapy and Sphincter-Sparing Surgery for a Low Rectal Cancer
- Nomograms of Kawai et al for a Patient with Stage IV Colorectal Cancer After Curative Resection: Disease-Free Survival (DFS)
- Nomograms of Kawai et al for a Patient with Stage IV Colorectal Cancer After Curative Resection: Overall Survival (OS)
- Tumor Budding in Colorectal Carcinomas
- Predictors of Yim et al for Lymph Node Metastases in a Patient with a T1 Colorectal Carcinoma Invading Into the Submucosa
- CRC-PRO Calculator of Wells et al for Colorectal Cancer: Nomogram for Males
- CRC-PRO Calculator of Wells et al for Colorectal Cancer: Nomogram for Females
- Score of Maeyama et al for Narrow-Band Imaging of a Colorectal Carcinoma
- Criteria of Sato et al for Venous Invasion in Colorectal Carcinoma
- SNACOR Score of Kim et al for a Patient Undergoing Chemoembolization for Hepatocellular Carcinoma
- Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma
- Transarterial Chemoembolization (TACE) Resistance Individualized Prediction (TRIP) Score of Sciarra et al for Hepatocellular Carcinoma
- Real-World Risk Score for Hepatocellular Carcinoma (RWS-HCC) of Poh et al
- Prognostic Nomogram of Xu et al for a Transcatheter Arterial Chemoembolization (TACE) in a Patient with Unresectable Hepatocellular Carcinoma
- VPEFR Risk Factors in Hepatoblastoma
- Risk Stratification for Hepatoblastoma from the Children's Hepatic Tumors International Collaboration
- Chiba HCC in Intermediate Prognostic (CHIP) Score of Ogasawara et al
- Clinical Risk Score (CRS) of Zheng et al for Recurrence of an Hepatocellular Carcinoma
- Mayo Staging System for Perihilar Cholangiocarcinoma
- MEGNA Score of Raoof et al for Intrahepatic Cholangiocarcinoma
- GI-NEC Score of Lamarca et al for High-Grade Gastrointestinal Neuroendocrine Carcinoma
- Prognostic Instrument of Manig et al for a Patient Irradiated for Recurrent Bladder Cancer
- Nomograms of Raut et al for Retroperitoneal Sarcoma: Disease-Free Survival (DFS)
- Nomograms of Raut et al for Retroperitoneal Sarcoma: Overall Survival (OS)
- Cytologic Features of Klijanienko et al Indicating a High Risk Neuroblastic Tumor
- Mitosis-Karyorrhexis Index (MKI)
- Heidelberg Prognostic Score for Recurrent Gliomas
- Prognostic Factors of Scholtyssek et al for a Progressive High-Grade Glioma Undergoing Re-Irradiation
- Squamous Cell Carcinoma Associated with Longstanding Hypertrophic Lichen Planus
- Prognostic Factors of Pfannschmidt et al Following Resection of Pulmonary Metastases from a Renal Cell Carcinoma
- Prediction Rule of Tello et al for Malignancy of a Hepatic Lesion Seen on MRI
- Krukenberg Tumor of the Ovary
- Staging System of Noura et al for Colorectal Cancer with Synchronous Peritoneal Metastases
- Clinical Score of Konopke et al for Survival After Resection of Colorectal Liver Metastases
- Prognostic Score of Nordlinger et al for Surgical Resection of Colorectal Carcinoma Metastases to the Liver
- Basingstoke Models for Survival After Resection of Hepatic Metastases from a Colorectal Cancer: Preoperative Score
- Basingstoke Models for Survival After Resection of Hepatic Metastases from a Colorectal Cancer: Postoperative Score
- Prognostic Model of Lise et al for a Patient Having Resection of Hepatic Metastases from a Colorectal Carcinoma
- Staging System of Ueno et al for a Patient with Hepatic Metastases from a Colorectal Carcinoma
- Scoring System of Nagashima et al for a Patient with Hepatic Metastases from a Colorectal Carcinoma
- Marrow Metastases Prognostic Score (MMPS) of Chou et al
- Prognostic Score of Regierer et al for Metastatic Breast Cancer
- Munich Score of Meimarakis et al for Predicting Long-Term Survival Following Resection of Pulmonary Metastases of a Renal Cell Carcinoma
- Prognostic Factors of Lin et al for a Patient Undergoing Pulmonary Metastasectomy for Sarcoma
- Palliative Care Screening Tool of Ostgathe et al for an Adult with Cancer
- Triggers for Suspecting Cancer By a General Practitioner
- HPV-Related Anogenital Carcinomas in Renal Transplant Recipients
- Modified Glasgow Prognostic Score (mGPS) and Cancer Survival
- Predictive Score of Lin et al for 90-Day Mortality for a Patient with Head and Neck Cancer Following Chemoradiation
- Composite Pathologic Risk Stratification of Cramer et al for Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma
- Staging System of Yueh et al for a Recurrent, Persistent or Second Primary Cancer of the Oral Cavity or Oropharynx
- Risk Factors of Morton et al for a Pharyngocutaneous Fistula Following Laryngectomy
- Histologic Features of Bondeson et al for a Parathyroid Carcinoma
- Criteria for the Diagnosis of Pulmonary Adenocarcinoma in Situ
- Criteria for the Diagnosis of Minimally Invasive Pulmonary Adenocarcinoma
- Prognostic Factors of Kondo and Monden for Thymoma or Thymic Carcinoma
- KiGE Index of Strand et al for a Woman with an N0 or N1 Breast Cancer
- CAGE Model of Strand et al for Prognosis in a Woman with Breast Cancer
- Model of Dingemans for Evaluating a Woman with Breast Cancer and a Positive Sentinel Lymph Node Biopsy
- Dutch Prediction Tool of van den Hoven et al for Risk of Metastases to Non-Sentinel Axillary Lymph Nodes in a Woman with Breast Cancer and a Positive Sentinel Node
- Nomogram of Shin et al for Predicting a Positive Resection Margin Following Breast-Conserving Surgery for Breast Cancer
- Nomogram of Lian et al for the Diagnosis of Intraductal Breast Cancer Using Ductoscopy
- Prediction Model of Meurs et al for Invasive Breast Cancer for a Woman with Ductal Carcinoma in Situ (DCIS) in a Breast Biopsy
- Model of Zhang et al for Predicting Axillary Lymph Node Metastases in a Chinese Woman with Breast Cancer
- Nomogram of Pleijhuis et al for Predicting Positive Surgical Margins at Breast-Conserving Surgery
- Nomograms of Duan et al for Esophageal Squamous Cell Carcinoma: Disease-Free Survival
- Nomograms of Duan et al for Esophageal Squamous Cell Carcinoma: Overall Survival
- Preoperative Nomogram of Goense et al for a Patient with Esophageal Adenocarcinoma
- Lymph Node Involvement in Carcinoma of the Esophagus
- Issues of Buckley et al in the CT Staging of a Small Bowel Adenocarcinoma
- Model of Backes et al for Predicting Metastases from a Pedunculated T1 Colorectal Carcinoma
- Difficulty Scores of Ban et al for Laparoscopic Liver Resection n
- Updated Barcelona Clinic Liver Cancer (BCLC) Staging Classification
- LabScore of Tsilimigras et al for a Patient with Intrahepatic Cholangiocarcinoma
- Nomogram of Groot Koerkamp et al for Survival After Resection of a Perihilar Cholangiocarcinoma (PHC)
- Findings of Tirotta et al Distinguishing a Benign from Malignant Proximal Biliary Stricture
- Preoperative Risk Score of Wiggers et al to Predict Occult Locally Advanced or Metastatic Perihilar Cholangiocarcinoma
- T Stage Criteria of Burke et al for Hilar Cholangiocarcinoma
- Japanese Society of Biliary Surgery (JSBS) Staging Classification for Gallbladder Cancer
- Prognostic Model of Gerken et al for Resectability of a Malignancy in the Head of the Pancreas
- Algorithm of Gerken et al for Managing a Patient with a Malignancy in the Head of the Pancreas
- Ratio of Pancreatic Duct Caliber to Width of the Pancreas (PDG Ratio)
- Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) Score of Klompmaker et al
- Characteristics of Paniccia et al for a Patient Who Survives 10 Years with Pancreatic Ductal Adenocarcinoma
- Nomogram of Huang et al for Predicting Survival of a Patient with Pancreatic Duct Adenocarcinoma
- Nomogram of Tol et al for Evaluating a Patient with a Pancreatic or Periampullary Cancer
- Use of Imaging Studies to Determine Resectability of a Pancreatic Adenocarcinoma
- Nomograms of He et al for Survival of a Patient with Periampullary Adenocarcinoma: Overall Survival
- Nomograms of He et al for Survival of a Patient with Periampullary Adenocarcinoma: Progression-Free Survival
- Prognostic Factors of Yamaguchi et al for a Pancreatoduodenal Carcinoma
- Clinical Features of Roggo et al for a Carcinoid Tumor of the Appendix
- Prognostic Factors of Janson et al for a Carcinoid Tumor
- Risk Factors of Burke et al for Metastases from a Carcinoid Tumor of the Duodenum
- Prognostic Factors of Roy and Chetty for Goblet Cell Carcinoid Tumors of the Appendix
- Prognostic Factors of Mekhail et al for Previously Untreated Metastatic Renal Cell Carcinoma
- Prognostic Model of Motzer et al for a Patient Treated with Interferon-Alfa for Advanced Renal Cell Carcinoma
- Prognostic Factors of Heng et al for a Patient with Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
- Prognostic Scores of Sylvester et al for a Ta or T1 Carcinoma of the Urinary Bladder
- Preoperative Nomogram of Petros et al for Predicting Non-Organ Confined Urothelial Carcinoma
- Prognostic Factors of Homesley et al for a Patient with Vulvar Carcinoma
- Prognostic Factors of Perez et al for Squamous Cell Carcinoma of the Cervix Treated with Radiation Alone
- Classification of Lapinska-Szumczyk et al for Endometrial Adenocarcinoma Using Estrogen Receptor, Progesterone Receptor and HER2
- Risk Factors of Creasman et al for Lymph Node Metastases in a Woman with Endometrial Cancer
- Metastatic Sites of Uterine Sarcoma
- Nomogram of Godoy et al for Prediction of Lymph Node Involvement in a Male with a Prostate Cancer
- Yonsei Nomogram of Kim et al to Predict Lymph Node Invasion in an Asian Male with Prostate Cancer
- Formula of Yu et al for Predicting Lymph Node Metastases in a Patient with Prostate Cancer (Yale Formula)
- Nomogram of Martini et al for Extracapsular Extension of Prostate Cancer
- Nomogram of Parker et al for Prediction of Recurrent Prostate Cancer with Extrapelvic Extension
- Nomogram of Winter et al for Predicting Sentinel Lymph Node Metastases from a Prostate Cancer
- Nomogram of Sayyid et al for Ipsilateral Extraprostatic Extension of Prostate Cancer
- Nomogram of Gandaglia et al for Extended Lymph Node Dissection for a Male with Prostate Cancer
- Nomogram of Zhu et al for Diagnosis of Prostate Cancer in a Chinese Adult Using p2PSA
- Model of Iyama et al for Distinguishing a Transition Zone Prostate Cancer from Benign Prostatic Hyperplasia (BPH)
- Nomogram of Martini et al for Predicting Seminal Vesicle Invasion (SVI) in a Patient with Prostate Cancer
- Nomogram of Steuber et al for Prediction of Extracapsular Extension for a Male with Prostate Cancer
- Score of Dutto et al for Insignificant Prostate Cancer
- Model of Cao et al for Predicting Lymph Node Metastases for a Chinese Male with Prostate Cancer
- Prognostic Model of Armstrong et al for Predicting Survival of a Chemotherapy Naive Male with Metastatic Castration-Resistant Prostate Cancer
- Predictors of Thompson et al for Prostate Cancer
- Nomogram of Han and Partin for Clinically Localized Prostate Cancer
- Table of Han and Partin for Clinically Localized Prostate Cancer
- Table of Makarov et al for Clinically Localized Prostate Cancer
- Table of Eifler et al for Clinically Localized Prostate Cancer
- Table of Tosoian et al for Clinically Localized Prostate Cancer
- 1997 Table of Partin et al for Clinically Localized Prostate Cancer
- 1993 Table of Partin et al for Clinically Localized Prostate Cancer
- Prognostic Factors of Lahat et al for a Soft Tissue Sarcoma in an Adult
- Manchester Criteria for Neurofibromatosis 2
- NIH Criteria for the Diagnosis of Neurofibromatosis Type 2
- Criteria of the National Neurofibromatosis Foundation (NNFF) for Neurofibromatosis 2
- Diagnostic Criteria for Schwannomatosis
- Juvenile Fibrosarcoma (Infantile Fibrosarcoma) of the Eyelid or Orbit
- Mucoepidermoid Carcinoma of the Conjunctiva
- Tumor Doubling Time (TDT) of a Uveal Melanoma
- Algorithm of Wright et al for the Diagnosis of a Lacrimal Gland Tumors
- Immunohistochemical Stains for Evaluating Sentinel Lymph Nodes for a Patient with Merkel Cell Carcinoma
- Nomogram of Wong et al for Predicting Metastasis to a Sentinel Lymph Node from a Malignant Melanoma
- Clinicopathologic Stages of Butchart et al for Diffuse Mesothelioma
- Nevoid Basal Cell Carcinoma Syndrome (NBCCS, Gorlin Syndrome, Basal Cell Nevus Syndrome)
- Prognostic Factors of Hofmann et al for a Patient Undergoing Pulmonary Metastasectomy from Renal Cell Carcinoma
- Clinical Findings Associated with Epidural Metastases with Spinal Cord Compression
- Delay of Diagnosis in a Patient with Spinal Cord Compression Due to Metastastic Carcinoma
- Peritoneal Surface Disease Severity Score (PSDSS) for Metastatic Colorectal Cancer to the Peritoneum
- Colorectal Peritoneal Metastases Prognostic Surgical Score (COMPASS) of Simkens et al
- Models of Segelman et al for Metachronous Peritoneal Carcinomatosis Associated with Colorectal Cancer: Model for Colon Cancer
- Models of Segelman et al for Metachronous Peritoneal Carcinomatosis Associated with Colorectal Cancer: Model for Rectal Cancer
- Volume-Time Index (VTI) in Peritoneal Metastases from a Colorectal Carcinoma
- Brain Metastasis Velocity (BMV)
- Nomogram of Jakub et al to Predict Upstaging of a Ductal Carcinoma in Situ (DCIS) to Invasive Breast Carcinoma
- Nomogram of Briganti et al for Predicting Lymph Node Invasion in a Patient with Prostate Cancer
- Naples Prognostic Score (NPS)
- Clinical Survival Prediction Model of Arends et al for Hypopharynx Cancer
- Nomogram of Zhang et al for Nonmetastatic Nasopharyngeal Carcinoma
- Major Salivary Gland Distant Metastases Risk Score of Lukovic et al
- Risk Categories of Schulte et al for Parathyroid Carcinoma
- TNM Classification of Schulte et al for Parathyroid Carcinoma
- Prognostic Factors of Villar-del-Moral et al for a Patient with Parathyroid Carcinoma
- Preoperative Score of Xue et al for the Diagnosis of Parathyroid Carcinoma
- Risk Scores of Suh et al for Papillary Carcinoma of the Thyroid: RSS1 Score
- Risk Scores of Suh et al for Papillary Carcinoma of the Thyroid: RSS2 Score
- Clinical Features of Parathyroid Carcinoma
- Parathyromatosis
- Risk Score of Ng et al for Predicting Survival of a Patient with EGFR-mutant Non-Small Cell Lung Cancer (NSCLC)
- VAGAS Score (Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms) of Puhr et al
- Models of Zhang et al for Survival in a Patient with Gastric Cancer: All Age Groups
- Models of Zhang et al for Survival in a Patient with Gastric Cancer: Older Adult
- Nomogram of Wu et al for Predicting Lymphatic Infiltration in Colorectal Cancer
- Nomograms of Zhang et al for Colorectal Adenocarcinoma: Cancer-Specific Survival
- GAG-HCC Scores of Yuen et al for Hepatocellular Carciinoma in a Patient with Chronic Hepatitis B: Core Promoter Mutation Testing Not Available
- CAMD Score for Predicting Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B Who Is Receiving Antiviral Therapy
- PAGE-B Score of Papatheodoridis et al for Risk of Hepatocellular Carcinoma in a Patient with Chronic Viral Hepatitis B on Antiviral Therapy
- HCC Prediction Score of Wong et al for Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B
- GAG-HCC Scores of Yuen et al for Hepatocellular Carciinoma in a Patient with Chronic Hepatitis B: Core Promoter Mutation Testing Available
- Predictors of Al-Mofleh et al for Malignant Biliary Strictures
- Nomogram of Gu et al for a Patient with Renal Cell Carcinoma and a Venous Tumor Thrombus
- Risk Factors of Chen et al for Mortality in a Patient with Renal Cell Carcinoma and an Associated Venous Tumor Thrombus
- CANLPH Score of Komura et al for a Patient with Renal Cell Carcinoma
- Model of Fan et al for Predicting the Risk of Bone Metastases in a Patient with Bladder Cancer
- Nomogram of Ouldamer et al for Predicting a Prognosis for a Woman with Endometrial Cancer
- Pathologic Findings of Scandura et al Predictive of Metastatic Disease at Presentation in a Male with Testicular Seminoma
- Nomograms of Yang et al for Predicting Survival for a Patient with Osteosarcoma: Nomogram A
- Nomograms of Yang et al for Predicting Survival for a Patient with Osteosarcoma: Nomogram B
- Models of Callegaro et al for a Patient with a Localized Soft Tissue Sarcoma of an Extremity: Overall Survival
- Models of Callegaro et al for a Patient with a Localized Soft Tissue Sarcoma of an Extremity: Distant Metastases
- Pigmented Basal Cell Carcinoma
- Paraneoplastic Syndromes Associated with Mesothelioma
- Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS)
- Prognostic Score of Katagiri et al for a Patient with Skeletal Metastases
- B2 Prognostic Index (B2PI) for Metastatic Breast Cancer
- Nomogram of Xiong et al for Survival in a Woman with Metastatic Breast Cancer
- Prognostic Index of Puente et al for a Woman with Metastatic Recurrent Breast Cancer
- Indications of Sugarbaker for Conservative Therapy When Considering a Debulking Procedure for Peritoneal Carcinomatosis
- Score of Nenclares et al for Predicting Overall Survival After Irradiation for Metastatic Spinal Cord Compression
- Functional Palliative Prognostic Index (FPPI) of Hiratsuka et al: Walking Score
- Functional Palliative Prognostic Index (FPPI) of Hiratsuka et al: Eating Score
- Functional Palliative Prognostic Index (FPPI) of Hiratsuka et al: Communicating Score
- Classification of Lagman et al for Ecchordis Physaliphoris and Chordoma
- Predictors of Komura et al for Cancer-Specific Survival for a Patient with Renal Cell Carcinoma
- Classification of Residual Tumor (R0, R1, R2)
- Nomograms of Fakhry et al for Oropharyngeal Cancer: Overall Survival
- Nomograms of Fakhry et al for Oropharyngeal Cancer: Progression-Free Survival
- Calcifying Epithelial Odontogenic Tumor (Pindborg Tumor, CEOT)
- Grading Scheme of Fuchs et al for Medullary Thyroid Carcinoma
- Model of Yu et al for Preoperative Prediction of Follicular Carcinoma in a Thyroid Nodule
- Staging Systems of Karadaghy et al for Nonmetastatic Papillary Thyroid Carcinoma: Functional Severity Staging System (FSSS)
- Staging Systems of Karadaghy et al for Nonmetastatic Papillary Thyroid Carcinoma: Clinical Severity Staging System (CSSS)
- Model of Strand for Predicting 30-Day Mortality Following Resection of a Lung Cancer
- Differentiation Between Type A and Type AB Thymomas
- Histologic Criteria for Atypical Type A Thymoma
- NCCN 2021 Updated Contraindications to Breast Conserving Therapy
- Indications for Prophylactic Mastectomy
- Findings Suggestive of a Genetic Risk for Breast Cancer: No Personal History of Cancer
- Findings Suggestive of a Genetic Risk for Breast Cancer: With a Personal History of Breast Cancer
- Gene Mutations Associated with Hereditary/Familial Breast Cancer
- Fibrinogen and Albumin (FA) Score for Prognosis of Esophageal Cancer
- Model of Chen et al for Predicting Mortality for a Patient with Squamous Cell Carcinoma of the Esophagus
- Score of Ahmadi et al for Distinguishing Malignant from Benign Esophageal Disease
- CAP/ASCP/ASCO Guideline for HER2 (ERBB2) Testing in Gastroesophageal Adenocarcinoma
- Gastric Cancer Peritoneal Carcinomatosis Risk Score of Ji et al
- Canton Score of Sun et al for Gastric Cancer
- Nomograms of Zhang et al for Colorectal Adenocarcinoma: Overall Survival
- Predictive Model of Imperiale et al for Advanced Colorectal Neoplasia in an Asymptomatic Adult
- HERACLES Diagnostic Criteria for HER2 (ERBB2) Scoring of a Colorectal Cancer
- Asia-Pacific Proximal Colon Neoplasia Risk Score
- Model of Dorajoo et al for Survival Following Primary Tumor Resection in Stage IV Colorectal Cancer with Unresectable Metastases
- Prognostic Scoring System of Kishiki et al for Incurable Stage IV Colorectal Cancer
- Nomogram of Chen et al for Predicting Survival for a Patient with a Gastrointestinal Stromal Tumor (GIST)
- Nomogram of Li et al for Predicting Recurrence-Free Survival for a Patient with a Primary Gastrointestinal Stromal Tumor (GIST)
- aMAP Score of Fan et al for Predicting Hepatocellular Carcinoma in a Patient with Chronic Hepatitis
- PANAMA Score of Hank et al for Predicting Survival After Therapy for Pancreatic Cancer
- MD Anderson Cancer Center (MDACC) Clinical Borderline Resectable Classification (CBRC) System for Pancreatic Cancer
- Nomogram of Ge et al for Predicting Survival of a Patient with a Metastatic Nonfunctioning Pancreatic Neuroendocrine Carcinoma
- Bilateral Renal Cell Carcinoma
- Cancer of the Bladder Risk Assessment (COBRA) Score
- Prognostic Factors of Ferrari et al for Primary Squamous Cell Carcinoma of the Vulva
- Model of Seebacher et al for Predicting Ovarian Cancer in a Patient with an Adnexal Mass
- Nomogram of Martini et al for Predicting Extracapsular Extension of Prostate Cancer
- Prognostic Factors of Gootee et al for a Patient with a Leiomyoscarcoma
- Model of Huq et al for Predicting the Discharge Location for a Hospitalized Patient Treated for a Brain Tumor
- Asan Intracranial Meningioma Scoring System (AIMSS) of Lee et al
- Grading System of Rutkowski et al for the Consistency of a Pituitary Adenoma
- Merkel Cell Polyomavirus and Merkel Cell Carcinoma
- Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome
- Risk of Sarcoma in a Patient with Hereditary Retinoblastoma
- Risk of Epithelial Carcinoma and Melanoma in a Patient with Hereditary Retinoblastoma
- Score of Kim et al for Predicting Survival Following Resection of Colorectal Liver Metastasis
- Nomogram of Beppu et al for Predicting Disease-Free Survival (DFS) After Resection of Colorectal Liver Metastases
- Model of Dai et al for Early Recurrence of Colorectal Liver Metastases
- Early Recurrence After Curative Hepatectomy for Liver Metastases from a Colorectal Carcinoma
- Prognostic Model of Amano et al Following Resection of Liver Metastases from a Colorectal Carcinoma
- Predictors of Nakajima et al for Site of Tumor Recurrence Following Hepatectomy for Metastatic Colorectal Cancer
- Prognostic Nomogram of Imai et al for a Patient with Initially Unresectable Colorectal Liver Metastases
- Urgent Chemotherapy for a Life-Threatening Complication of a Solid Malignancy
- Sekhar Grading System for a Cranial Chordoma (SGSCC)
- FA (Fibrinogen and Albumin) Score of Li et al for Skull Base Chordoma
- Challenges in the Diagnosis of Chordoma
- Clinical and Radiological Features of a Skull Base Chordoma
- Hopkins Response Criteria for a Head and Neck Cancer on a FDG-PET/CT Scan
- Prognostic Nomogram of Zhuang et al for a Patient an Oral Squamous Cell Carcinoma
- iBD Model of Yu et al for a Patient with a Squamous Cell Carcinoma of the Tongue
- Prognostic Score of Chen et al for a Patient with Nasopharyngeal Cancer and Bone Metastases
- Prognostic Factors of Tian et al for a Patient with Nasopharyngeal Carcinoma and Synchronous Liver Metastasis
- Model of Xia et al for Predicting Distant Metastases in a Patient with Nasopharyngeal Carcinoma
- Risk Factors of Cao et al for Survival in a Patient with Nasopharyngeal Carcinoma with Bone Metastases
- Prognostic Factors of Cao et al for Mortality of a Patient with Lung Metastasis from a Nasopharyngeal Carcinoma
- Sonographic Score of Lo et al for Prediction of a Major Salivary Gland Tumor
- TALK Score of Sherman et al for Predicting Larynx Preservation in a Patient with Laryngeal Cancer
- Model of Fang et al for Predicting Papillary Thyroid Carcinoma Based on Ultrasonographic Features of a Thyroid Nodule
- Lung Cancer Prognostic Index of Alexander et al for Predicting Survival After the Diagnosis of Non-Small-Cell Lung Cancer (NSCLC): Full Model (LCPI)
- Lung Cancer Prognostic Index of Alexander et al for Predicting Survival After the Diagnosis of Non-Small-Cell Lung Cancer (NSCLC): Modified Model (m-LCPI)
- Model of Wang et al for a Patient with a Small Cell Lung Cancer (SCLC)
- Nomogram of Tang et al for Predicting Survival of a Patient with a Neuroendocrine Tumor of the Thymus
- Nomogram of Zhao et al for Predicting Survival of a Patient with Thymoma
- Margin Index for Ductal Carcinoma In Situ (DCIS) of the Breast
- Model of D'Journo et al 90-Day Mortality Following Esophagectomy for Cancer
- Prognostic Score of Lu et al for a Patient with Gastric Cancer Following Gastrectomy
- Clinical Stage Prediction (CSP) Score of Taniguchi et al for Staging Gastric Cancer
- Geriatric Risk Score of Souwer et al for an Older Patient with Colorectal Cancer
- Endoscopic Score of Kakushima et al for Differentiating Between a Duodenal Adenoma and Adenocarcinoma
- Early-Onset (Young-Onset) Colorectal Cancer (EOCRC)
- Preoperative Calculator of Gabriel et al for Predicting Survival Following Resection of a Hepatocellular Carcinoma
- Prognostic Score of Wang et al for a Patient with Hepatocellular Carcinoma
- Nomogram of Hyder et al for Predicting Survival of a Patient with an Intrahepatic Cholangiocarcinoma
- Nomogram of Ma et al for Survival After Surgical Resection of a Gallbladder Cancer
- Nomogram of Ma et al for Predicting Survival of a Patient with a Left-Sided Pancreatic Adenocarcinoma After Surgical Resection
- Prognostic Factors of Akkaya et al for a Woman with Adenocarcinoma of the Fallopian Tube
- Score of Pradjatmo et al for Malignancy in a Hydatidiform Mole
- HALP and HALPG Scores of Guo et al for Predicting Prognosis for a Patient with Metastatic Prostate Cancer
- Updated IGCCCG Prognostic Factors for Metastatic Seminoma
- Risk Score Model of Dong et al for Predicting Metastases for a Patient with an Osteosarcoma
- Prognostic Model of Cao et al for a Patient with Liposarcoma
- Hibernoma
- REM (Risk of Endometrial Malignancy) Model of Angioli et al
- Clinical Prediction Model of Brims et al for a Patient with Malignant Pleural Mesothelioma
- Pathologic Fracture Mortality Index (PFMI) of Raad et al
- Risk Model of Anzuategui et al for a Patient Undergoing Spinal Metastasis Surgery
- Prognostic AL Score of Shi et al for a Patient with a Malignant Pleural Effusion
- Score of Cao et al for Survival Following Palliative Primary Tumor Resection in a Patient with Unresectable Metastatic Colorectal Cancer
- Risk Factors of Dunlap et al for Chyle Leak Following Radical Neck Dissection
- Prognostic Model for Advanced Cancer (PRO-MAC) of Hum et al
- Model of Bourdel-Marchasson et al for Predicting 1-Year Mortality for an Older Adult with Cancer
- Glasgow Microenvironment Score (GMS)
- BD Score of Almangush et al for a Patient with a Squamous Cell Carcinoma of the Tongue
- Model of Dong et al for Predicting Survival for a Patient with a Typical Lung Carcinoid Tumor
- Predictors of Rueth et al for Complications Following Surgical Resection in an Older Adult with Non-Small Cell Lung Cancer
- Prognostic Models of Miyoshi et al for a Patient with Stage IV Colorectal Cancer After Concurrent Curative Resection: Nomogram for Cancer-Specific Survival (CSS)
- Prognostic Models of Miyoshi et al for a Patient with Stage IV Colorectal Cancer After Concurrent Curative Resection: Nomogram for Relapse-Free Survival (RFS)
- Model of Weiser et al for Predicting Survival for a Patient with Locally Advanced Rectal Cancer
- Neoadjuvant Rectal (NAR) Score Following Preoperative Chemoradiation
- Nomogram of Kanemitsu et al for Predicting Overall Survival for a Patient with a Colon Cancer
- Classification of Dworak et al for Regression of a Rectal Cancer Following Preoperative Chemoradiation
- AGMA Score of Sotiropoulos et al for a Patient Undergoing Liver Transplant for Hepatocellular Carcinoma
- Vanderbilt Clinical Score of Das et al for Predicting Progression-Free Survival for a Patient with a Neuroendocrine Tumor Following Lu-177 Dotatate Therapy
- 2019 World Health Organization (WHO) Classification of Neuroendocrine Neoplasms (NEN) of the Gastrointestinal and Hepatobiliary Organs
- Prognostic Factors of Begum et al for Neuroendocrine Carcinoma with Unknown Primary (CUP)
- Virilizing Adrenocortical Carcinoma in a Pediatric Patient
- O-RADS MRI Classification for an Adnexal Mass
- Hedienreich Criteria for Retroperitoneal Lymph Node Dissection for Post-Chemotherapy Residual Masses in a Patient with Nonseminomatous Germ Cell Tumor of the Testis
- Prognostic Model of Zhou et al for a Patient with Ewing Sarcoma of Bone
- Classification of Trouillas et al for Pituitary Adenomas
- Algorithm of Guaraldi et al for Evaluating a Patient with a Pituitary Neuroendocrine Tumor (Adenoma)
- Dermatofibrosarcoma Protuberans (DFSP) Associated with Severe Combined Immunodeficiency (SCID)
- PTEN Hamartoma Tumor Syndrome (PHTS)
- Models of Tseng et al for a Patient with Disseminated Malignancy Undergoing Surgical Intervention: Model for 30-Day Morbidity
- Models of Tseng et al for a Patient with Disseminated Malignancy Undergoing Surgical Intervention: Model for 30-Day Mortality
- Magnetic Resonance Grading Scheme of Tian et al for Skull Base Chordoma (SBC)
- Nomogram of Zou et al for Predicting Survival of a Patient with a Spinal Chordoma
- PADUA (Preoperative Aspects and Dimensions Used for an Anatomical) Score of Ficarra et al for a Renal Tumor
- Serum Lactate Dehydrogenase (LDH) to Absolute Lymphocyte Count Ratio
- PILE Score in a Patient Treated with Anti-PD-1 or Anti-PD-L1 Inhibitors
- Prediction Score of Said et al for Oral Cavity Cancer
- Prognostic Score of Lupato et al for Recurrent Squamous Cell Carcinoma of the Head and Neck
- International Medullary Thyroid Carcinoma Grading System (IMTCGS)
- VA Lung Cancer Mortality (VALCAN-M) Score of Heiden et al
- Prognostic Scores of del Arco et al for a Patient with Resected Gastric Cancer
- Risk Factors of Park et al for Recurrence and Death Following Complete Surgical Resection of Stage I Gastric Cancer
- Primary Tumor Score (PTS) and Other Prognostic Markers of Haraguchi et al for Resectable Gastric Cancer
- Prognostic Score of Qian et al for a Patient with Resectable Gastric Cancer
- Score of Sekiguchi et al for Predicting Lymph Node Metastases in Early Gastric Cancer
- Prognostic Factors of Shiraishi et al for a Patient with a Large Gastric Cancer
- Aspartate Aminotransferase (AST) to Lymphocyte Ratio Index (ALRI) for Predicting Survival in Patients with Hepatocellular Carcinoma
- Six and Twelve Prognostic Model of Wang et al for Transarterial Chemoembolization (TACE) of an Hepatocellular Carcinoma (HCC)
- Platelet-Albumin-Bilirubin (PALBI) Prognostic Score for Hepatocellular Carcinoma
- Platelet-Albumin (PAL) Prognostic Score of Shindoh et al for Hepatocellular Carcinoma
- EZ-ALBI (Albumin-Bilirubin) Prognostic Score for Hepatocellular Carcinoma
- Prognostic Factors of Ho et al for a Patient with Hepatocellular Carcinoma
- Singapore Liver Cancer Recurrence (SLICER) Score of Ang et al
- Histologic Tumor Regression Grading (HRTG) Score of Chatterjee et al for Pancreatic Adenocarcinoma
- Pancreatic Head Tumor (PHT) Score of Muttillo et al
- Risk Factors of Armstrong et al for Progression of an Intraductal Papillary Mucinous Neoplasm (IPMN)
- Model of Bereza-Carlson et al for Early Mortality Following Surgery for Pancreatic Cancer (SPEM)
- Zonal NePhRO Score of Hakky et al for Renal Tumor Complexity Classification
- Zero Ischemia Index (ZII) of Li et al for a Patient Undergoing Partial Nephrectomy for a Renal Tumor
- Zhongshan Score (ZS) of Zhou et al for a Patient with a Renal Tumor
- Renal Tumor Invasion Index (RTII)
- Surgical Approach Renal Ranking (SARR) for a Patient with a Renal Tumor
- Simplified PADUA Renal (SPARE) Nephrometry Score for a Patient with a Partial Nephrectomy
- Centrality Index (C Index) for a Renal Tumor
- Renal Tumor Contact Surface Area (CSA)
- Diameter-Axial-Polar (DAP) Nephrometry
- Nomogram of Sheng et al for Predicting a High-Grade Cervical Lesion
- Algorithm of Vang and Shih for the Diagnosis of Serous Tubal Intra-Epithelial Neoplasia
- Models of Xu et al for a Patient with R0 Resected Head and Neck Soft Tissue Sarcoma: Inflammatory-Nutrition Score (INS)
- Models of Xu et al for a Patient with R0 Resected Head and Neck Soft Tissue Sarcoma: Nomogram Using the Inflammatory-Nutrition Score (INS)
- Models of Xu et al for a Patient with R0 Resected Head and Neck Soft Tissue Sarcoma: Nomogram Without the Inflammatory-Nutrition Score (INS)
- Prognostic Score of Villard et al for Survival of a Patient with Colorectal Liver Metastases
- Model of Owusuaa et al for Predicting 1-Year Mortality for a Patient with Advanced Cancer
- Laboratory Prognostic Score (GI-LPS) of Nagai et al for a Terminally Ill Patient with Gastrointestinal Malignancy
- Predictors of Christ et al for 72-Hour Mortality for a Patient Admitted to an Acute Palliative Care Unit
- Anti-NMDA Receptor (NMDAR) Autoimmune Encephalitis Associated with an Ovarian Teratoma
- Risk Models of Rampoldi et al for Surgical Mortality in Acute Type A Aortic Dissection (International Registry of Acute Aortic Dissection Score, IRAADS): Preoperative Model
- Nomograms of Wang et al for a Patient with Buccal Cancer: Nomogram for Overall Survival
- Nomograms of Wang et al for a Patient with Buccal Cancer: Nomogram for Cancer Specific Survival
- Nomogram of Zhou et al for Predicting Survival for a Patient with an Oral Squamous Cell Carcinoma
- Nomogram of Lu et al for Predicting Lymph Node Metastasis for a Patient with Papillary Thyroid Carcinoma
- Score of Lee et al for Predicting 2-Year Survival in a Patient with a Stage I to III Non-Small Cell Carcinoma of the Lung (NSCLC)
- SABCIP Score of Tahara et al for Predicting In-Hospital Death After Lung Cancer Surgery
- Immune-Based Prognostic Risk Score (IMPRS) of He et al for Non-Small Cell Lung Cancer (NSCLC): Nomogram A
- Immune-Based Prognostic Risk Score (IMPRS) of He et al for Non-Small Cell Lung Cancer (NSCLC): Nomogram B
- Nomogram of Guo et al for Selecting a High-Risk Patient in China for CT Lung Screening
- VIOLA Score of Puhr et al for a Patient with Esophagogastric Adenocarcinoma
- Score of Chang et al for Prognosis in a Patient with Esophageal Cancer Treated with Immune Checkpoint Inhibitor
- Model of Pan et al for Predicting Serosal Invasion By a Gastric Cancer
- Nomogram of Valentini et al for Predicting 5-Year Mortality for a Patient with Locally Advanced Rectal Cancer
- Prognostic Factors of Wu et al for Gastrointestinal Stromal Tumors (GIST)
- Nomogram of Chen for Predicting Survival in a Patient with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
- CRAFITY Score of Scheiner et al for Evaluating a Patient with Hepatocellular Carcinoma for Immunotherapy
- Nomogram of Zhang et al for Predicting the Risk of Cancer in a Gallbladder Polyp
- Nomogram of Jiang et al for Predicting Malignancy in a Pancreatic Cystic Neoplasm
- WHO Reporting System for Pancreaticobiliary Cytopathology
- Prognostic Index of Huang et al for a Patient with Pancreatic Cancer
- CRP-Bellmunt Score of Abuhelwa et al for Urothelial Carcinoma Treated with Immunotherapy
- Vesical Imaging Reporting and Data System (VI-RADS) Score for the Urinary Bladder
- Nomogram of Wang et al for Predicting Lymphovascular Space Invasion (LVSI) in a Patient with Endometrial Cancer
- Copenhagen Index (CPH-I) for Ovarian Cancer
- Prognosis Predictive Score Around Primary Debulking Surgery (PPSP) of Kawahara et al for a Woman with Ovarian Cancer
- Risk Scores of Salas et al for a Patient with a Solitary Fibrous Tumor
- Risk Score of Georgiesh et al (G-Score) for a Solitary Fibrous Tumor
- Revised Score of Demicco et al for Predicting Risk of Metastases in a Patient with Solitary Fibrous Tumor
- Risk Score of Thompson et al for an Orbital Solitary Fibrous Tumor
- Risk Score of Pasquali et al for a Patient with an Extra-Pleural and Extra-Meningeal Solitary Fibrous Tumor (SFT)
- Risk Factors of Segal et al for an Unacceptable Delay in the Diagnosis of a Primary Intradural Spinal Cord Tumor
- Immune-Related Risk Score of Ren et al for Predicting Survival for a Patient with Glioblastoma
- Malignant Pleural Effusion (MPE) Score of Chantharakhit and Sujaritvanichpong
- Clinical Risk Scores of Brudvik et al for Predicting Survival After Resection of Colorectal Cancer Liver Metastases
- Predictors of Frosch et al for a Delay in the Start of Cancer Therapy
- Cancer Survival Index (CSI) of Gaiger et al
- Metastatic Uveal Melanoma Prognostic Score (MUMPS) of Kelly et al
- Predictors of Neck Dissection Failure in a Patient with an Oropharyngeal Squamous Cell Carcinoma